# Association of specific microbiota taxa in the amniotic fluid at birth with severe acute and longer-term outcomes of very preterm infants: a prospective observational study.

<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med</journal-id><journal-id journal-id-type="iso-abbrev">BMC Med</journal-id><journal-title-group><journal-title>BMC Medicine</journal-title></journal-title-group><issn pub-type="epub">1741-7015</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">12275360</article-id><article-id pub-id-type="publisher-id">4259</article-id><article-id pub-id-type="doi">10.1186/s12916-025-04259-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association of specific microbiota taxa in the amniotic fluid at birth with severe acute and longer-term outcomes of very preterm infants: a prospective observational study</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Staude</surname><given-names>Birte</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gschwendtner</surname><given-names>Silvia</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Frodermann</surname><given-names>Tina</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Oehmke</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kohl</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Walch</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Schloter</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Ehrhardt</surname><given-names>Harald</given-names></name><address><email>harald.ehrhardt@uniklinik-ulm.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/045f0ws19</institution-id><institution-id institution-id-type="GRID">grid.440517.3</institution-id><institution>Department of General Pediatrics and Neonatology, </institution><institution>Justus Liebig University and Universities of Giessen and Marburg Lung Center, </institution></institution-wrap> Giessen, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/021ft0n22</institution-id><institution-id institution-id-type="GRID">grid.411984.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0482 5331</institution-id><institution>Division of Neonatology and Pediatric Intensive Care Medicine, Department of Pediatrics and Adolescent Medicine, </institution><institution>University Medical Center Ulm, </institution></institution-wrap>Ulm, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cfam450</institution-id><institution-id institution-id-type="GRID">grid.4567.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 0483 2525</institution-id><institution>Research Unit for Comparative Microbiome Analysis, Helmholtz Zentrum M&#x000fc;nchen, </institution><institution>German Research Center for Environmental Health, </institution></institution-wrap>Neuherberg, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033eqas34</institution-id><institution-id institution-id-type="GRID">grid.8664.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2165 8627</institution-id><institution>Department of Gynecology and Obstetrics, </institution><institution>Justus Liebig University of Giessen, </institution></institution-wrap>Giessen, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/031bsb921</institution-id><institution-id institution-id-type="GRID">grid.5601.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0943 599X</institution-id><institution>German Center for Fetal Surgery and Minimally Invasive Therapy (DZFT), </institution><institution>University of Mannheim (UMM), </institution></institution-wrap>Mannheim, Germany </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>23</volume><elocation-id>431</elocation-id><history><date date-type="received"><day>26</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>4</day><month>7</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par3">Dysbiotic microbial colonization predisposes to severe outcomes of prematurity, including mortality and severe morbidities like necrotizing enterocolitis (NEC), late-onset infection (LOI) and bronchopulmonary dysplasia (BPD). Here, we studied the variations in the bacterial signatures in the amniotic fluid (AF) of very preterm deliveries&#x02009;&#x0003c;&#x02009;32 weeks with severe acute and longer-term outcomes within a prospective cohort study.</p></sec><sec><title>Methods</title><p id="Par4">One hundred twenty-six AF samples were available for 16S rRNA gene metabarcoding to describe bacterial community structure and diversity in connection to intraventricular haemorrhage (IVH), LOI, focal intestinal perforation (FIP), NEC, retinopathy of prematurity (ROP) and the 2-year cognitive (MDI) and motor (PDI) outcome.</p></sec><sec><title>Results</title><p id="Par5">Diversity and overall bacterial community composition did not differ between the studied outcomes. But disparities in sequences assigned to single bacterial taxa were observed for the acute outcomes LOI and ROP and the longer-term impairments of MDI and PDI. Enrichments associated with a poor acute outcome were particularly detected in the <italic>Escherichia-Shigella</italic> cluster, while the predominance of <italic>Ureaplasma</italic> and <italic>Enterococcus</italic> species was associated with unrestricted acute and longer-term outcomes. Analysis for FIP did not reach any significance. IVH and NEC constituted rare events, prohibiting the analyses.</p></sec><sec><title>Conclusions</title><p id="Par6">Our data provide evidence that microbiota patterns at birth might allow the early identification of infants at risk for the severe outcomes of prematurity and argue against morbidity-specific associations. The data support the early origins hypothesis and relevant contribution of prenatal factors. The partly existing disparities between acute and longer-term outcomes might be traced back to the relevant impact of the diverse longitudinal exposures and socioeconomic factors.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12916-025-04259-9.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Preterm infant</kwd><kwd>Amniotic fluid</kwd><kwd>16S rRNA</kwd><kwd>Microbiome</kwd><kwd>Respiratory distress</kwd><kwd>Late-onset infection</kwd><kwd>Intraventricular haemorrhage</kwd><kwd>Bronchopulmonary dysplasia</kwd><kwd>Retinopathy of prematurity</kwd><kwd>Psychomotor outcome</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>KFO309/2</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsklinikum Ulm (8941)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par20">During recent years, it became more and more evident that physiologic microbial signatures are relevant for somatic and mental health across the lifespan [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Microbial dysbiosis has been linked to major morbidities of all organs and to major and epidemiologically relevant acute and chronic diseases [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Thereby, direct microbiota effects were determined for the lung and gastrointestinal tract, but remote actions via microbial axes were described for the endocrine function and the brain as well, and associations were observed across the complete life span [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. For the newborn infant, aberrant microbial colonization at or after birth has been described as a major trigger for persistent changes in the microbiota structures and associated with chronic diseases later in life, including allergic diseases like asthma, autoimmunologic disorders, diabetes and neurodegenerative disorders [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. While the observational studies in humans can only provide associations but were not able to prove causality, experimental models undoubtedly documented the patho-mechanistic link between dysbiotic microbiota structures and disease origin [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>].
</p><p id="Par21">Very preterm (VPT) infants are at high risk for severe acute morbidities during their initial stay in the neonatal intensive care unit (NICU) including bronchopulmonary dysplasia (BPD), intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and late onset infections (LOI), which have dramatic consequences for the overall acute health status and the long-term perspective [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>]. Despite all the advances in medical care during their stay in the NICU, VPT infants are still at high risk for impairment and long-term sequelae, and the overall disease burden was not reduced for most of the outcomes during the last 25 years [<xref ref-type="bibr" rid="CR18">18</xref>]. This unmet need was attributed to the prenatal origins of the diseases, which was best studied for BPD, where, for example, amniotic infection and preeclampsia/eclampsia/HELLP are drivers for prenatal disease development [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. For BPD, sophisticated newborn animal models have confirmed the role of dysbiotic microbiota structures and microbial toxins as disease drivers. These observations are likely also true for the other severe outcomes [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Congruent insights were obtained in prospective observational cohort studies in preterm infants with analyses of their microbiota structures. The colonization of the respiratory tract directly after birth with bacterial species which have the potential to act as pathogens during the stay in the NICU was associated with a more severe pulmonary outcome [<xref ref-type="bibr" rid="CR20">20</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. The prenatal origins of BPD were recently confirmed on amniotic fluid samples obtained immediately before delivery. While the microbiota signatures differed vastly from that of intact pregnancies, they did not reveal overall disparities in the total microbial load or diversity between the different severity stages of BPD, except for partly increased evenness. But variations in amplicon sequence variants (ASV) assigned to the <italic>Escherichia-Shigella</italic> cluster and <italic>Gardnerella</italic>, <italic>Enterococcus</italic> and <italic>Ureaplasma</italic> species were associated with BPD disease severity [<xref ref-type="bibr" rid="CR24">24</xref>]. Together, these data explain why postnatal improvements in medical care did not prevent BPD but were only suited to alleviate the postnatal aggravation of lung injury and severity stage of BPD [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. While best studied for the immature lung, for the infection-triggered diseases of LOI and NEC as well, convincing evidence exists that the clinical management, including antibiotic therapy and provision of breast milk, highly impacts the microbiota structures and risks [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. For the other severe outcomes of prematurity, like IVH or ROP, and the longer-term psychomotor outcome, such well-founded experimental insights or profound association studies are so far not available.</p><p id="Par22">Here we evaluated the associations of bacterial signatures in the amniotic fluid at birth with the outcomes of VPT birth within a prospective cohort study. We assessed variations in diversity, overall community composition and ASV assigned to specific bacteria for the various acute severe outcomes and the cognitive and motor outcome at 2 years of age.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population and definition of baseline characteristics and outcomes</title><p id="Par23">We executed our analyses on the recently described population of preterm infants&#x02009;&#x0003c;&#x02009;32 weeks of gestation that were prospectively enrolled within the PROTECT-AIRR cohort study at the perinatal centre Giessen between July 2015 and May 2020. The study was conducted according to the rules of the Declaration of Helsinki, was approved by the ethics committee at the Justus-Liebig-University of Gie&#x000df;en (Az 135/12) and was registered at the DRKS (DRKS00004600). After provision of oral information, we obtained written informed consent from the parents of all preterm infants participating in the study.</p><p id="Par24">The clinical data of patients included in the study were retrieved from the electronic data management system and the paper file records, as done before [<xref ref-type="bibr" rid="CR29">29</xref>]. Baseline maternal and neonatal characteristics included gestational age at delivery, birth weight and z-score, gender, mode of delivery, cause for preterm delivery, birth as singleton or multiple and Apgar score. Small for gestational age (SGA) status was defined as birth weight&#x02009;&#x0003c;&#x02009;10th percentile according to the nomograms of the German perinatal registry [<xref ref-type="bibr" rid="CR30">30</xref>]. Prenatal antibiotic therapy was documented when applied within the last 7 days before delivery. Cause of preterm delivery for intra-amniotic infection was counted when at least one of the following criteria was fulfilled: documented histologic chorioamnionitis, an elevated amniotic fluid (AF) interleukin-6&#x02009;&#x0003e;&#x02009;3600pg/ml, the presence of intractable premature contractions during tocolytic therapy or the premature rupture of membranes before the onset of labour. The presence and severity of BPD were graded according to the NICHD consensus definition as applied recently. Infants who required supplemental oxygen for&#x02009;&#x02265;&#x02009;28 days of life were categorized as mild BPD if they were on room air without any respiratory support at 36 weeks postmenstrual age. If infants required supplemental oxygen&#x02009;&#x0003c;&#x02009;30% at 36 weeks, they were categorized as moderate BPD and with&#x02009;&#x02265;&#x02009;30% of oxygen and/or need for positive pressure support as severe BPD [<xref ref-type="bibr" rid="CR31">31</xref>]. High-flow nasal cannula therapy was accepted to provide continuous positive airway pressure with a PEEP equivalent of&#x02009;&#x02265;&#x02009;3 cm H2O and calculation of the fraction of oxygen by low-flow nasal cannula was done as published recently [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. IVH severity was staged from the ultrasound examinations using the Deeg definition [<xref ref-type="bibr" rid="CR34">34</xref>] and maximum stage of ROP from the screening examinations executed during clinical routine. LOI were counted when the criteria of the German NICU nosocomial surveillance system (NEO-KISS) were fulfilled [<xref ref-type="bibr" rid="CR35">35</xref>]. Cognitive (MDI) and motor (PDI) outcomes at 24 months corrected age were evaluated with the Bayley III assessment battery. Clinically relevant cognitive and motor deficits were accepted with a score&#x02009;&#x0003c;&#x02009;85 as published before [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p></sec><sec id="Sec4"><title>Amniotic fluid sample collection</title><p id="Par25">AF samples were obtained during routine caesarean delivery; for four cases, the collection was executed during amniotic puncture immediately before the decision to VPT delivery. As all AF samples were obtained by amniotic puncture or during caesarean section immediately before delivery, microbial contamination of samples during spontaneous delivery by the microbiota of the birth channel was excluded. AF samples were directly collected into sterile pyrogen-free protein low-bind tubes (Eppendorf SE, Hamburg, Germany) and immediately stored at&#x02009;&#x02212;&#x02009;80&#x000b0; until analysis.</p></sec><sec id="Sec5"><title>DNA extraction, 16S rRNA gene sequencing and data processing</title><p id="Par26">Bacterial DNA extraction, 16S ribosomal RNA (16S rRNA) gene sequencing and data analyses were all executed as described recently [<xref ref-type="bibr" rid="CR24">24</xref>]. Shortly, AF samples of 1.5mL in volume were centrifuged before pellet digestion with lysozyme (20 mg/ml) and Proteinase K (20 mg/ml) and DNA extraction with phenol&#x02013;chloroform [<xref ref-type="bibr" rid="CR38">38</xref>]. Subsequently, the V3&#x02013;V4 hypervariable region of the 16S rRNA gene was amplified. Indexing PCR products were purified with AMPure XP beads and quantified on Fragment Analyzer&#x02122; (Advanced Analytical Technologies, Inc., Ankeny, USA) before sequencing on a MiSeq Illumina instrument (MiSeq Reagent Kit v3 (600 Cycle); Illumina, San Diego, CA, USA) [<xref ref-type="bibr" rid="CR39">39</xref>]. For contamination surveillance, parallel blank extraction samples and PCR no-template controls were included (<italic>n</italic>&#x02009;=&#x02009;3; for one, no PCR product could be obtained). Only FASTQ files with a minimum read length of 50 and a minimum Phred score of 15 were included in the final analysis performed with the QIIME 2 software package (version 2019.10.0) using the DADA2 plugin for quality control and SILVA_132_QIIME release 99% for taxonomic assignment [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Blank samples showed clearly reduced richness and higher evenness as well as different bacterial community composition compared to AF samples (Additional File 1: Additional Figure S1). To exclude potential contamination, ASV occurring in extraction and PCR controls were removed from the dataset (33 and 2 ASV, respectively) (Additional File&#x000a0;2: Table&#x000a0;S1). Additionally, mitochondrial sequences and singletons were removed, resulting in 1,558,601 reads in total, ranging from 69,785 to 114 reads per sample (median 12,771 reads per sample) (Additional File 2: Table S2).</p><p id="Par27">Rarefaction curve analysis showed a sufficient sampling depth at 5000 reads (Additional file 1: Figure S2). Consequently, samples with reads&#x02009;&#x0003c;&#x02009;5000 (<italic>n</italic>&#x02009;=&#x02009;39) were excluded from subsequent analysis, and data normalization was done by subsampling to 5434 reads (the lowest obtained read number in remaining samples, <italic>n</italic>&#x02009;=&#x02009;77). All sequence data of the study are deposited in the short read archive of NCBI and accession number PRJNA1260988.</p></sec><sec id="Sec6"><title>Quantitative real&#x02011;time PCR</title><p id="Par28">Quantitative real-time PCR (qPCR) of the 16S rRNA gene as proxy for bacterial load was performed as described previously [<xref ref-type="bibr" rid="CR24">24</xref>], using primers FP 16S/RP 16S and the following PCR conditions: 10 min at 95&#x000a0;&#x000b0;C; 40 cycles of 45 s at 95&#x000a0;&#x000b0;C, 45 s at 58&#x000a0;&#x000b0;C, 45 s at 72&#x000a0;&#x000b0;C; 10 min 72&#x000a0;&#x000b0;C; 1 cycle of 15 s at 95&#x000a0;&#x000b0;C, 30 s at 60&#x000a0;&#x000b0;C, 15 s at 95&#x000a0;&#x000b0;C. The quantified gene copy numbers were normalized to 1 ml of amniotic fluid. The bacterial load in blank extraction controls and PCR no template controls (<italic>n</italic>&#x02009;=&#x02009;15) ranged from below detection level to one to three orders of magnitude lower compared to AF samples (Additional file 1: Additional Figure S1).</p></sec><sec id="Sec7"><title>Statistical analysis</title><p id="Par29">All statistics were performed in R version 4.2.1 (<ext-link ext-link-type="uri" xlink:href="https://www.R-project.org">https://www.R-project.org</ext-link>). Qualitative data were analysed with chi-square test and Fisher test as appropriate and with Benjamini&#x02013;Hochberg adjustment for multiple comparisons. Bacterial loads quantified via qPCR were analysed using Kruskal&#x02013;Wallis test and Wilcoxon-rank sum test, as appropriate. Alpha diversity was calculated using species richness based on ASV number, Pielou&#x02019;s evenness and Shannon diversity index. Beta diversity was analysed via unweighted and weighted UniFrac distance. For statistical purposes, Kruskal&#x02013;Wallis test, Wilcoxon-rank sum test and PERMANOVA with Benjamini&#x02013;Hochberg <italic>p</italic> value correction for multiple comparisons were used. To identify microbial taxa differing between the analysed groups, a generalized linear model (R package MASS) was used. For model validation, residual histograms, plots showing sample quantiles versus theoretical quantiles and plots showing residuals versus fitted values were checked for normal distribution and variance homogeneity of residuals [<xref ref-type="bibr" rid="CR42">42</xref>]. Significant differences (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) were calculated via ANOVA respective Wilcoxon and Kruskal&#x02013;Wallis test using Benjamini&#x02013;Hochberg <italic>p</italic> value adjustment for multiple pairwise comparisons. Additionally, differential expression analysis via edgeR was performed to verify the model results. Only taxa with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 in both methods were considered as significant. Plots were created in R using ggplot2, ggpubr and metacoder. Additionally, linear regression with the outcomes of richness as well as abundance of <italic>Bifidobacteria</italic>, <italic>Enterococcus</italic>, <italic>Ureaplasma</italic> and <italic>Escherichia-Shigella</italic>, respectively, was used to identify possible confounding by birth weight.</p></sec></sec><sec id="Sec8"><title>Results</title><sec id="Sec9"><title>Cohort characteristics</title><p id="Par30">Clinical outcome data and amniotic fluid (AF) samples obtained immediately before delivery were available from overall 126 VPT infants. Seven patients were excluded from the analyses due to death before 36 weeks of gestation, where we were not able to determine the outcomes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Two infants were excluded for heart surgery for congenital heart defects and one after complications due to milk aspiration. A further 39 infants were excluded as their AF samples rendered low bacterial reads [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Infants with low bacterial reads did not differ in their baseline characteristics or outcomes compared to infants included in the analyses (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Overall, 77 infants were available for the acute outcomes studied. Follow-up data were available for MDI from 63 and for PDI from 60 infants (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Further infant characteristics are detailed specifically for each outcome analysed within the respective subsequent sections.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Study population flow chart.&#x000a0;Flow chart of inclusion and exclusion of infants into the study population. Exclusion criteria included AF samples with low read bacterial signal, death before the outcome estimates and the severe morbidities of prematurity with high impact on the outcomes studied. ROP, retinopathy of prematurity; IVH, intraventricular haemorrhage; LOI, late onset infection (&#x0003e;72 hours after birth); FIP, focal intestinal perforation; MDI, mental developmental index; PDI, psychomotor developmental index</p></caption><graphic xlink:href="12916_2025_4259_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline characteristics and outcomes separated into infants included into the analysis and infants excluded for a low number of reads in the amniotic fluid samples</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">Exclusion for low reads</th></tr><tr><th align="left"/><th align="left">Included</th><th align="left">Low read</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;77</th><th align="left">n&#x02009;=&#x02009;39</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="4">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (26,30)</td><td align="left">27 (26,29)</td><td align="left">0.69</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">960 (750,1350)</td><td align="left">950 (775,1145)</td><td align="left">0.46</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">12 (15.6%)</td><td align="left">9 (23.1%)</td><td align="left">0.46</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">34 (44.2%)</td><td align="left">19 (48.7%)</td><td align="left">0.79</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">44 (57.1%)</td><td align="left">21 (53.8%)</td><td align="left">0.89</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">74 (96.1%)</td><td align="left">38 (97.4%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.36</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">34 (44.2%)</td><td align="left">13 (33.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">14 (18.2%)</td><td align="left">12 (30.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">14 (18.2%)</td><td align="left">5 (12.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">15 (19.5%)</td><td align="left">9 (23.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">0.88</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">19 (24.7%)</td><td align="left">10 (25.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">39 (50.6%)</td><td align="left">21 (53.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">19 (24.7%)</td><td align="left">8 (20.5%)</td><td align="left"/></tr><tr><td align="left" colspan="4">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">0.71</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">31 (40.3%)</td><td align="left">13 (33.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">27 (35.1%)</td><td align="left">14 (35.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">19 (24.7%)</td><td align="left">12 (30.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">0.36</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">48 (62.3%)</td><td align="left">20 (51.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">18 (23.4%)</td><td align="left">14 (35.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">11 (14.3%)</td><td align="left">5 (12.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">4 (5.19%)</td><td align="left">1 (2.56%)</td><td align="left">0.66</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">11 (14.3%)</td><td align="left">9 (23.1%)</td><td align="left">0.36</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">7 (9.09%)</td><td align="left">1 (2.56%)</td><td align="left">0.26</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;NEC</td><td align="left">0 (0.0%)</td><td align="left">0 (0.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>19 (30.2%)</p><p>(na&#x02009;=&#x02009;14)</p></td><td align="left"><p>7 (30.4%)</p><p>(na&#x02009;=&#x02009;7)</p></td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>14 (23.3%)</p><p>(na&#x02009;=&#x02009;17)</p></td><td align="left"><p>6 (26.1%)</p><p>(na&#x02009;=&#x02009;6)</p></td><td align="left">1.00</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with the proportion in brackets. Quantitative data is presented as median with 1st and 3rd quartiles in square brackets. For statistical analyses, Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD </italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP </italic>retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Microbial signatures at birth and severe outcomes during the longitudinal stay in the NICU</title><p id="Par31">First, we evaluated the bacterial 16S rRNA gene signatures in the AF of infants with further acute severe outcomes of prematurity occurring during the longitudinal course in the NICU. For ROP, we segregated infants by the maximum disease severity into no ROP (<italic>n</italic>&#x02009;=&#x02009;48), non-severe ROP (<italic>n</italic>&#x02009;=&#x02009;18) and severe ROP (<italic>n</italic>&#x02009;=&#x02009;11) where the last category included all stage 3 cases or higher at high risk for impaired visual acuity irrespective of the indication for ROP therapy or not. Infants with severe ROP had a lower gestational age (median 25 vs 28 weeks) and birth weight (median 590&#x02009;g vs 1230&#x02009;g) at birth; further baseline characteristics and outcomes are detailed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Whereas bacterial load was significantly higher in the non-severe group, alpha and beta diversity did not differ between AF samples of infants for the three ROP categories (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a and b, Additional File 1: Additional Figure S3a). But differences on single genus level were observed: When AF samples of infants with severe ROP were compared to the non-severe ROP category, ASV assigned to the <italic>Escherichia</italic>-<italic>Shigella</italic> group and <italic>Kocuria</italic> were more abundant in AF samples of infants with severe ROP while <italic>Ureaplasma</italic>, <italic>Bifidobacterium, Gardnerella and Enterococcus</italic> species displayed higher abundance in AF samples of infants with non-severe ROP (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>c). For IVH and LOI, FIP and NEC, total bacterial loads, alpha and beta diversity were analysed using the identical approach, and no statistically significant differences were observed. AF samples of infants who developed LOI had a lower abundance of ASV assigned to <italic>Ureaplsma and Mycoplasma</italic>. No significant differences could be observed for FIP. IVH constituted a rare event (four cases) in our cohort, prohibiting reliable in-depth statistical analysis due to highly unbalanced data. Consequently, analysis on single genera was not performed (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, Additional File 1: Additional Fig.&#x000a0;3b-d, Tables <xref rid="Tab3" ref-type="table">3</xref>, <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref>). Analyses for NEC were not performed, as there was only one case with NEC in our cohort. As birth weight prevailed as the only patient characteristic that displayed significant differences throughout the comparisons of infants with and without a severe morbidity, we additionally executed linear regression analyses. Throughout the analyses, no significant associations were detected between birth weight and bacterial richness as well as the species of interest, excluding birth weight as a possible confounder (Additional File 2: Supplemental Table S3).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Baseline characteristics of infants separated by the severity of retinopathy of prematurity</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="5">ROP</th></tr><tr><th align="left"/><th align="left">No ROP</th><th align="left">Non-severe</th><th align="left">Severe</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;48</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;18</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;11</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="5">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">29 (28,30)</td><td align="left">26 (25,27)</td><td align="left">25 (24,25)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">1230 (948,1452)</td><td align="left">812 (668,938)</td><td align="left">590 (535,695)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">5 (10.4%)</td><td align="left">2 (11.1%)</td><td align="left">5 (45.5%)</td><td align="left">0.021</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">21 (43.8%)</td><td align="left">8 (44.4%)</td><td align="left">5 (45.5%)</td><td align="left">0.99</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">23 (47.9%)</td><td align="left">15 (83.3%)</td><td align="left">6 (54.5%)</td><td align="left">0.034</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">46 (95.8%)</td><td align="left">17 (94.4%)</td><td align="left">11 (100%)</td><td align="left">0.75</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.17</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">18 (37.5%)</td><td align="left">13 (72.2%)</td><td align="left">3 (27.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">9 (18.8%)</td><td align="left">3 (16.7%)</td><td align="left">2 (18.2%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">10 (20.8%)</td><td align="left">1 (5.56%)</td><td align="left">3 (27.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">11 (22.9%)</td><td align="left">1 (5.56%)</td><td align="left">3 (27.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.14</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">13 (27.1%)</td><td align="left">4 (22.2%)</td><td align="left">2 (18.2%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">20 (41.7%)</td><td align="left">10 (55.6%)</td><td align="left">9 (81.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">15 (31.2%)</td><td align="left">4 (22.2%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left" colspan="5">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left"/><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">28 (58.3%)</td><td align="left">3 (16.7%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">16 (33.3%)</td><td align="left">10 (55.6%)</td><td align="left">1 (9.09%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">4 (8.33%)</td><td align="left">5 (27.8%)</td><td align="left">10 (90.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">2 (4.17%)</td><td align="left">1 (5.56%)</td><td align="left">1 (9.09%)</td><td align="left">0.77</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">1 (2.08%)</td><td align="left">4 (22.2%)</td><td align="left">6 (54.5%)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">2 (4.17%)</td><td align="left">1 (5.56%)</td><td align="left">4 (36.4%)</td><td align="left">0.012</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>8 (21.6%)</p><p>(na&#x02009;=&#x02009;11)</p></td><td align="left"><p>5 (31.2%)</p><p>(na&#x02009;=&#x02009;2)</p></td><td align="left"><p>6 (60.0%)</p><p>(na&#x02009;=&#x02009;1)</p></td><td align="left">0.075</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>4 (11.4%)</p><p>(na&#x02009;=&#x02009;13)</p></td><td align="left"><p>4 (23.5%)</p><p>(na&#x02009;=&#x02009;1)</p></td><td align="left"><p>6 (75.0%)</p><p>(na&#x02009;=&#x02009;3)</p></td><td align="left">0.001</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with proportion in brackets. Quantitative data is presented as median with 1<sup>st</sup>and 3<sup>rd</sup> quartile in square brackets. For statistical analyses Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD&#x000a0;</italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP&#x000a0;</italic>retinopathy of prematurity, <italic>FIP&#x000a0;</italic>focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Differences in 16S rRNA gene microbial abundance in AF samples from preterm deliveries and ROP. <bold>a&#x000a0;</bold>Alpha diversity measured as Shannon diversity index shows no significant (<italic>p</italic> &#x0003c; 0.05) difference between AF samples of preterm deliveries with no (blue), non-severe (orange) and severe (red) retinopathy of prematurity (ROP). Statistical analysis was performed using Wilcoxon Rank-Sum test. <bold>b</bold>&#x000a0;NMDS plot of weighted Unifrac distances shows no significant (<italic>p</italic> &#x0003c; 0.05) altered bacterial 16S rRNA gene community composition for AF samples of preterm deliveries from Figure 2a. Statistical analysis was performed using PERMANOVA with Benjamini-Hochberg correction for multiple comparisons. <bold>c</bold>&#x000a0;Heat tree of log-fold changes calculated with edgeR including top 100 genera (accounting for 97% of all reads in median). The labelled tree on the left shows the taxonomic information (domain to genus) and is the key for the unlabelled smaller trees. Smaller trees represent a comparison between no, non-severe and severe ROP. Coloured taxa are more abundant in the samples indicated by the coloured subtitle. Significant changes (p &#x0003c; 0.05 in both edgeR and generalized linear model) are marked with green asterisks</p></caption><graphic xlink:href="12916_2025_4259_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Differences in 16S rRNA gene microbial abundance in AF samples from preterm deliveries and IVH/LOI/FIP. <bold>a</bold>&#x000a0;Alpha diversity (Shannon index) index and beta diversity (NMDS plot of weighted Unifrac distances) shows no significant (p &#x0003c; 0.05) difference in AF samples of preterm deliveries with (red) and without (blue) intraventricular haemorrhage (IVH). Statistical analysis was performed using Wilcoxon Rank-Sum test and PERMANOVA with Benjamini-Hochberg correction for multiple comparisons, respectively. <bold>b</bold>&#x000a0;Alpha diversity (Shannon index) index and beta diversity (NMDS plot of weighted Unifrac distances) shows no significant (<italic>p</italic> &#x0003c; 0.05) difference in AF samples of preterm deliveries with (red) and without (blue) late onset infection (LOI). Statistical analysis was performed using Wilcoxon Rank-Sum test and PERMANOVA with Benjamini-Hochberg correction for multiple comparisons, respectively. <bold>c</bold>&#x000a0;Alpha diversity (Shannon index) index and beta diversity (NMDS plot of weighted Unifrac distances) shows no significant (<italic>p</italic> &#x0003c; 0.05) difference in AF samples of preterm deliveries with (red) and without (blue) focal intestinal perforation (FIP). Statistical analysis was performed using Wilcoxon Rank-Sum test and PERMANOVA with Benjamini-Hochberg correction for multiple comparisons, respectively. <bold>d</bold>&#x000a0;Heat tree of log-fold changes calculated with edgeR including top 100 genera (accounting for 97% of all reads in median). The labelled upper tree shows the taxonomic information (domain to genus) and is the key for the unlabelled smaller trees. Smaller trees represent a comparison between the patient groups from Figure 4b and 4c, respectively (blue: increased in 0, red: increased in 1)
. Significant changes (<italic>p</italic> &#x0003c; 0.05 in both edgeR and generalized linear model) are marked with green asterisks</p></caption><graphic xlink:href="12916_2025_4259_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab3"><label>Table 3</label><caption><p>Baseline characteristics of infants with and without intraventricular haemorrhage</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">IVH</th></tr><tr><th align="left"/><th align="left">No IVH</th><th align="left">IVH</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;73</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;4</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="4">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (26,30)</td><td align="left">26 (25,28)</td><td align="left">0.26</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">970 (770,1350)</td><td align="left">788 (652,1089)</td><td align="left">0.46</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">11 (15.1%)</td><td align="left">1 (25.0%)</td><td align="left">0.50</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">33 (45.2%)</td><td align="left">1 (25.0%)</td><td align="left">0.63</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">43 (58.9%)</td><td align="left">1 (25.0%)</td><td align="left">0.31</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">70 (95.9%)</td><td align="left">4 (100%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.48</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">32 (43.8%)</td><td align="left">2 (50.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">14 (19.2%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">14 (19.2%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">13 (17.8%)</td><td align="left">2 (50%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">18 (24.7%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">37 (50.7%)</td><td align="left">2 (50.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">18 (24.7%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left" colspan="4">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">0.55</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">30 (41.1%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">26 (35.6%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">17 (23.3%)</td><td align="left">2 (50.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">0.77</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">46 (63%)</td><td align="left">2 (50.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">17 (23.3%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">10 (13.7%)</td><td align="left">1 (25.0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">10 (13.7%)</td><td align="left">1 (25.0%)</td><td align="left">0.47</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">7 (9.59%)</td><td align="left">0 (0%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>17 (28.3%)</p><p>(na&#x02009;=&#x02009;13)</p></td><td align="left"><p>2 (66.7%)</p><p>(na&#x02009;=&#x02009;1)</p></td><td align="left">0.21</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>14 (24.1%)</p><p>(na&#x02009;=&#x02009;15)</p></td><td align="left"><p>0 (0%)</p><p>(na&#x02009;=&#x02009;2)</p></td><td align="left">1.00</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with proportion in brackets. Quantitative data is presented as median with&#x000a0;1st and 3rd quartiles in square brackets. For statistical analyses, Kruskal&#x02013;Wallis and Pearson tests were used as&#x000a0;appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD </italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP </italic>retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor&#x000a0;developmental index</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Baseline characteristics of infants with and without late-onset infection</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">Infection</th></tr><tr><th align="left"/><th align="left">No infection</th><th align="left">Infection</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;66</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;11</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="4">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (27,30)</td><td align="left">25 (24,25)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">982 (855,1390)</td><td align="left">570 (540,675)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">8 (12.1%)</td><td align="left">4 (36.4%)</td><td align="left">0.06</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">27 (40.9%)</td><td align="left">7 (63.6%)</td><td align="left">0.28</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">35 (53%)</td><td align="left">9 (81.8%)</td><td align="left">0.15</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">63 (95.5%)</td><td align="left">11 (100%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.96</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">28 (42.4%)</td><td align="left">6 (54.5%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">12 (18.2%)</td><td align="left">2 (18.2%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">13 (19.7%)</td><td align="left">1 (9.09%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">13 (19.7%)</td><td align="left">2 (18.2%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">0.12</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">16 (24.2%)</td><td align="left">3 (27.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">31 (47%)</td><td align="left">8 (72.7%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;7&#x000a0;days</td><td align="left">19 (28.8%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left" colspan="4">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">31 (47%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">25 (37.9%)</td><td align="left">2 (18.2%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">10 (15.2%)</td><td align="left">9 (81.8%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">47 (71.2%)</td><td align="left">1 (9.09%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">14 (21.2%)</td><td align="left">4 (36.4%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">5 (7.58%)</td><td align="left">6 (54.5%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">3 (4.55%)</td><td align="left">1 (9.09%)</td><td align="left">0.47</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">4 (6.06%)</td><td align="left">3 (27.3%)</td><td align="left">0.06</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>13 (24.5%)</p><p>(na&#x02009;=&#x02009;13)</p></td><td align="left"><p>6 (60.0%)</p><p>(na&#x02009;=&#x02009;1)</p></td><td align="left">0.06</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>9 (18.0%)</p><p>(na&#x02009;=&#x02009;16)</p></td><td align="left"><p>5 (50.0%)</p><p>(na&#x02009;=&#x02009;1)</p></td><td align="left">0.08</td></tr></tbody></table><table-wrap-foot><p>&#x000a0;Qualitative data is presented as n with the proportion in brackets. Quantitative data is presented as median with 1st and 3rd quartiles in square brackets. For statistical analyses, Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD </italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP </italic>retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Baseline characteristics of infants with and without focal intestinal perforation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">FIP</th></tr><tr><th align="left"/><th align="left">No FIP</th><th align="left">FIP</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;70</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;7</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="4">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (27,30)</td><td align="left">25 (24.5,27)</td><td align="left">0.015</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">970 (805,1358)</td><td align="left">590 (555,895)</td><td align="left">0.047</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">9 (12.9%)</td><td align="left">3 (42.9%)</td><td align="left">0.072</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">32 (45.7%)</td><td align="left">2 (28.6%)</td><td align="left">0.45</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">41 (58.6%)</td><td align="left">3 (42.9%)</td><td align="left">0.45</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">67 (95.7%)</td><td align="left">7 (100%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.89</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">31 (44.3%)</td><td align="left">3 (42.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">13 (18.6%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">12 (17.1%)</td><td align="left">2 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">14 (20%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">0.67</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">18 (25.7%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">34 (48.6%)</td><td align="left">5 (71.4%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">18 (25.7%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left" colspan="4">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">0.11</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">30 (42.9%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">25 (35.7%)</td><td align="left">2 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">15 (21.4%)</td><td align="left">4 (57.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">0.012</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">46 (65.7%)</td><td align="left">2 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">17 (24.3%)</td><td align="left">1 (14.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">7 (10%)</td><td align="left">4 (57.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">4 (5.71%)</td><td align="left">0 (0%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">8 (11.4%)</td><td align="left">3 (42.9%)</td><td align="left">0.056</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>17 (29.3%)</p><p>(na&#x02009;=&#x02009;12)</p></td><td align="left"><p>2 (40.0%)</p><p>(na&#x02009;=&#x02009;2)</p></td><td align="left">0.63</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left"><p>11 (20.0%)</p><p>(na&#x02009;=&#x02009;15)</p></td><td align="left"><p>3 (60.0%)</p><p>(na&#x02009;=&#x02009;2)</p></td><td align="left">0.780</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with proportion in brackets. Quantitative data is presented as median with 1st and 3rd quartiles in square brackets. For statistical analyses Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD </italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP </italic>retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Species-level microbiota variations and psychomotor outcome at 2 years of age</title><p id="Par32">Lastly, we evaluated the association of specific microbial 16S rRNA gene signatures in the AF at birth with the cognitive and motor outcome at 2 years of age using the Bayley III Scales of Infant Development. Infants with an MDI&#x02009;&#x0003c;&#x02009;85 were of lower gestational age (median: 25 vs 28 weeks) and were more likely to also have a PDI&#x02009;&#x0003c;&#x02009;85 (Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>). Infants with a PDI&#x02009;&#x0003c;&#x02009;85 were significantly more immature (median 25 vs 28 weeks) and had a lower birth weight (median 590 g vs 970 g) had more BPD and severe ROP (Table&#x000a0;<xref rid="Tab7" ref-type="table">7</xref>). No differences in total bacterial loads, alpha and beta diversity in AF samples were observed between infants with an MDI or PDI&#x02009;&#x02265;&#x02009;85 versus&#x02009;&#x0003c;&#x02009;85 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a and b, Additional File 1: Figure S3e and S3f). But on the single genus level, enrichment in <italic>Enterococcus</italic> species in AF samples was associated with a normal outcome for both the MDI and PDI, while for <italic>Ureaplasma</italic> species, this was given only for PDI (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). For the <italic>Escherichia-Shigella</italic> cluster, no significant differences were detected even when the sample was restricted to those infants at highest risk for psychomotor impairment with a diagnosis of ROP, while the presence of <italic>Enterococcus</italic> and <italic>Ureaplasma</italic> prevailed highly significantly with an unrestricted psychomotor outcome (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c).
<table-wrap id="Tab6"><label>Table 6</label><caption><p>Baseline characteristics of infants with and without mental deficits</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">MDI</th></tr><tr><th align="left"/><th align="left">MDI&#x02009;&#x02265;&#x02009;85</th><th align="left">MDI&#x02009;&#x0003c;&#x02009;85</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;44</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;19</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="4">Baseline characteristics</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (27,30)</td><td align="left">27 (25,29)</td><td align="left">0.03</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">960 (792,1240)</td><td align="left">870 (560,1200)</td><td align="left">0.11</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">6 (13.6%)</td><td align="left">4 (21.1%)</td><td align="left">0.47</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">22 (50%)</td><td align="left">8 (42.1%)</td><td align="left">0.76</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">27 (61.4%)</td><td align="left">12 (63.2%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">42 (95.5%)</td><td align="left">19 (100%)</td><td align="left">0.87</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.23</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">16 (36.4%)</td><td align="left">10 (52.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">12 (27.3%)</td><td align="left">1 (5.26%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">9 (20.5%)</td><td align="left">4 (21.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">7 (15.9%)</td><td align="left">4 (21.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">0.43</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">11 (25%)</td><td align="left">6 (31.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">26 (59.1%)</td><td align="left">8 (42.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">7 (15.9%)</td><td align="left">5 (26.3%)</td><td align="left"/></tr><tr><td align="left" colspan="4">Morbidities and outcomes</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">0.06</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">17 (38.6%)</td><td align="left">6 (31.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">19 (43.2%)</td><td align="left">4 (21.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">8 (18.2%)</td><td align="left">9 (47.4%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">0.08</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">29 (65.9%)</td><td align="left">8 (42.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">11 (25%)</td><td align="left">5 (26.3%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">4 (9.09%)</td><td align="left">6 (31.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">1 (2.27%)</td><td align="left">2 (10.5%)</td><td align="left">0.21</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">4 (9.09%)</td><td align="left">6 (31.6%)</td><td align="left">0.05</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">3 (6.82%)</td><td align="left">2 (10.5%)</td><td align="left">0.63</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;PDI&#x02009;&#x0003c;&#x02009;85</td><td align="left">3 (7.14%) (na&#x02009;=&#x02009;2)</td><td align="left">10 (58.8%) (na&#x02009;=&#x02009;2)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with the proportion in brackets. Quantitative data is presented as median with 1st and 3rd quartiles in square brackets. For statistical analyses Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>:<italic> AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD</italic> bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP</italic> retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap><table-wrap id="Tab7"><label>Table 7</label><caption><p>Baseline characteristics of infants with and without psychomotor developmental deficits</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="4">PDI</th></tr><tr><th align="left"/><th align="left">PDI&#x02009;&#x02265;&#x02009;85</th><th align="left">PDI&#x02009;&#x0003c;&#x02009;85</th><th align="left"><italic>p</italic> value</th></tr><tr><th align="left"/><th align="left"><italic>n</italic>&#x02009;=&#x02009;46</th><th align="left"><italic>n</italic>&#x02009;=&#x02009;14</th><th align="left"/></tr></thead><tbody><tr><td align="left" colspan="3">Baseline characteristics</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Weeks</td><td align="left">28 (27,29.8)</td><td align="left">25.5 (24.2,27)</td><td align="left">0.0037</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Birth weight [g]</td><td align="left">970 (839,1240)</td><td align="left">590 (555,838)</td><td align="left">0.0035</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Small for gestational age</td><td align="left">5 (10.9%)</td><td align="left">5 (35.7%)</td><td align="left">0.08</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Female</td><td align="left">21 (45.7%)</td><td align="left">8 (57.1%)</td><td align="left">0.65</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Singleton</td><td align="left">27 (58.7%)</td><td align="left">11 (78.6%)</td><td align="left">0.30</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Caesarean section</td><td align="left">44 (95.7%)</td><td align="left">14 (100%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Aetiology of preterm birth</td><td align="left"/><td align="left"/><td align="left">0.45</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;AIS</td><td align="left">19 (41.3%)</td><td align="left">8 (57.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;HELLP/preeclampsia</td><td align="left">10 (21.7%)</td><td align="left">1 (7.14%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;IUGR</td><td align="left">9 (19.6%)</td><td align="left">4 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Other</td><td align="left">8 (17.4%)</td><td align="left">1 (7.14%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ANCS</td><td align="left"/><td align="left"/><td align="left">0.077</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;None/&#x0003c;&#x02009;24&#x000a0;h</td><td align="left">11 (23.9%)</td><td align="left">6 (42.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;24&#x000a0;h&#x02013;7&#x000a0;days</td><td align="left">24 (52.2%)</td><td align="left">8 (57.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x0003e;&#x02009;7&#x000a0;days</td><td align="left">11 (23.9%)</td><td align="left">0 (0%)</td><td align="left"/></tr><tr><td align="left" colspan="3">Morbidities and outcomes</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;BPD severity</td><td align="left"/><td align="left"/><td align="left">0.027</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No BPD</td><td align="left">19 (41.3%)</td><td align="left">3 (21.4%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Mild BPD</td><td align="left">19 (41.3%)</td><td align="left">3 (21.4%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Moderate/severe BPD</td><td align="left">8 (17.4%)</td><td align="left">8 (57.1%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;ROP severity</td><td align="left"/><td align="left"/><td align="left">0.001</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;No ROP</td><td align="left">31 (67.4%)</td><td align="left">4 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Non-severe ROP</td><td align="left">13 (28.3%)</td><td align="left">4 (28.6%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;&#x02009;Severe ROP</td><td align="left">2 (4.35%)</td><td align="left">6 (42.9%)</td><td align="left"/></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;IVH</td><td align="left">2 (4.35%)</td><td align="left">0 (0%)</td><td align="left">1.00</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;Infection</td><td align="left">5 (10.9%)</td><td align="left">5 (35.7%)</td><td align="left">0.076</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;FIP</td><td align="left">2 (4.35%)</td><td align="left">3 (21.4%)</td><td align="left">0.078</td></tr><tr><td align="left">&#x02009;&#x02009;&#x02009;&#x02009;MDI&#x02009;&#x0003c;&#x02009;85</td><td align="left">7 (15.2%)</td><td align="left">10 (76.9%) (na&#x02009;=&#x02009;1)</td><td align="left">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table><table-wrap-foot><p>Qualitative data is presented as n with the proportion in brackets. Quantitative data is presented as median with 1st and 3rd quartiles in square brackets. For statistical analyses, Kruskal&#x02013;Wallis and Pearson tests were used as appropriate</p><p><italic>Abbreviations</italic>: <italic>AIS</italic> amnion infection syndrome, <italic>IUGR</italic> intrauterine growth restriction, <italic>ANCS</italic> antenatal corticosteroids, <italic>BPD </italic>bronchopulmonary dysplasia, <italic>ROP</italic> retinopathy of prematurity, <italic>IVH</italic> intraventricular haemorrhage, <italic>ROP </italic>retinopathy of prematurity, <italic>FIP</italic> focal intestinal perforation, <italic>MDI</italic> mental developmental index, <italic>PDI</italic> psychomotor developmental index</p></table-wrap-foot></table-wrap><fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Differences in 16S rRNA gene microbial abundance in AF samples from preterm deliveries and neurological development. <bold>a</bold>&#x000a0;Alpha diversity (Shannon index) and beta diversity (NMDS plot of weighted Unifrac distances) shows no significant (p &#x0003c; 0.05) difference in AF samples of preterm deliveries with mental developmental index (MDI) &#x02265;85 (0, blue) and
&#x0003c;85 (1, red). Statistical analysis was performed using Wilcoxon Rank-Sum test and PERMANOVA with Benjamini-Hochberg correction for multiple comparisons, respectively. <bold>b</bold>&#x000a0;Alpha diversity (Shannon index) and beta diversity (NMDS plot of weighted Unifrac distances) shows no significant (<italic>p</italic> &#x0003c; 0.05) difference in AF samples of preterm deliveries with psychomotor developmental index (PDI) &#x02265;85 (0, blue) and
&#x0003c;85 (1, red). Statistical analysis was performed using Wilcoxon Rank-Sum test and PERMANOVA with Benjamini-Hochberg correction for multiple comparisons, respectively. <bold>c</bold>&#x000a0;Heat tree of log-fold changes calculated with edgeR including top 100 genera (accounting for 97% of all reads in median). The labelled tree on the left shows the taxonomic information (domain to genus) and is the key for the unlabelled smaller trees. Smaller trees represent a comparison between the patient groups from Figure 4a and 4b, respectively (blue: increased in patients with index &#x02265;85, red: increased in patients with index &#x0003c;85). The upper coloured trees include all patients (without those with missing outcome), the lower coloured trees only patients with ROP, left trees results for the MDI and right trees those for the PDI. Significant changes (<italic>p</italic> &#x0003c; 0.05 in both edgeR and generalized linear model) are marked with green asterisks</p></caption><graphic xlink:href="12916_2025_4259_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec12"><title>Discussion</title><p id="Par33">Our data indicate that 16S rRNA gene signatures in the AF immediately before delivery differ between VPT infants, dependent on their acute and longer-term severe outcomes. While we recently described an association with the pulmonary outcome and the severity stages of BPD, we now provide evidence that comparable connections apply to further morbidities of prematurity [<xref ref-type="bibr" rid="CR24">24</xref>]. This is not surprising as the important contribution of microbiota to health and disease was confirmed across the different organ systems and many disease entities [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR4">4</xref>]. Furthermore, the prominent role of bacterial infections in these morbidities was shown in the preclinical models and association studies in preterm infants [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. The results of our study expand the association to the colonization at birth, as both infants with and without infections were at a higher risk for acute severe outcomes when specific bacterial strains were detected in their amniotic fluid at birth. While we described associations between the postnatal colonization with strains with potential pathogenicity and risk of BPD before, we now expand this association to the situation before preterm delivery [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The importance of the data arises from the fact that it might provide insights into why postnatal therapies to reduce the risk of BPD, ROP or psychomotor impairment are only of limited efficacy when the initial injurious event occurred already before birth.</p><sec id="Sec13"><title>Disparity in associations for the acute and longer-term morbidities</title><p id="Par34">We did not detect an association of the Escherichia&#x02013;Shigella cluster with the longer-term cognitive and motor impairment at 2 years of age. This might be surprising at first sight, but it has been well-described that the multiple longitudinal exposures during the stay in the NICU, variations in follow-up care and the socio-economic status of the family have a high impact that might be more relevant than the perinatal risks [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In line with our actual results, no associations between a low 5-min Apgar score and the 5-year psychomotor outcome were detected despite the close association with the acute severe outcomes [<xref ref-type="bibr" rid="CR48">48</xref>&#x02013;<xref ref-type="bibr" rid="CR50">50</xref>]. Our results are further substantiated by a recent analysis on the missing association of chorioamnionitis and the 5-year psychomotor outcome [<xref ref-type="bibr" rid="CR51">51</xref>].</p></sec><sec id="Sec14"><title>Putting the results into the context of the published literature</title><p id="Par35">We were able to ascribe the associations to ASV assigned to specific bacterial genera with all severe outcomes in this and our previous analysis when the frequency of events allowed a valid statistical approach, while the overall diversity and community composition remained unchanged [<xref ref-type="bibr" rid="CR24">24</xref>]. Most importantly and uniformly within the analyses, members of <italic>Escherichia&#x02013;Shigella</italic> prevailed as the most relevant cluster associated with all acute severe outcomes, while enrichment in <italic>Enterococcus</italic> and <italic>Ureaplasma</italic> species complex mostly prevailed associated with better acute and unrestricted psychomotor outcomes. This is not surprising when considering the high frequency of detection of bacterial strains from the <italic>Escherichia&#x02013;Shigella</italic> complex in connection with all acute severe morbidities in the clinics and the convincing experimental evidence that these strains with their LPS production induce signalling pathway alterations including activation of inflammation that result in injuries of the immature lung, eye and brain, which is comparable to the better studied and highly relevant postnatal injury of hyperoxia exposure [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR52">52</xref>&#x02013;<xref ref-type="bibr" rid="CR54">54</xref>]. In that direction, it was demonstrated before that microbiota structure dysbiosis drives innate immune responses and metabolomic pathologies that explain the prenatal damage to the immature organs of the preterm infant [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. While we observed mostly congruent results for the <italic>Escherichia&#x02013;Shigella</italic> cluster throughout the analyses on the acute outcomes, there were disparities in the results for <italic>Enterococcus</italic> species [<xref ref-type="bibr" rid="CR24">24</xref>]. This might reflect that some of the outcomes get differentially impacted by specific microbiota structures at birth, in addition to the larger differential impact on the longer-term outcomes, opening another dimension of diversity.</p></sec><sec id="Sec15"><title>Appeal for studies of varying pathogenicity on the single bacterial strain level</title><p id="Par36">Due to the sample size, we were not able to provide association studies for further bacterial signatures with high pathogenicity, as their frequency of detection was too low in our cohort, in line with other studies on this topic [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. We were not able to address the interaction of different bacterial strains as described in sophisticated animal studies, for example, for preceding <italic>Ureaplasma</italic> species colonization of the amniotic cavity before the exposure to LPS from <italic>Escherichia coli</italic> that restricted the pro-inflammatory response following LPS by inducing an immunotolerance phenotype [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Vice versa, those bacterial genera without the potential to induce pathogenicity and which have been described as important for the development of the infants like <italic>Bifidobacterium species</italic> were associated with a better outcome in our study, except for non-severe ROP compared to no ROP where we cannot provide a solid explanation. From this, it is imperative to expand the actual analyses beyond genus to the single strain to specify particularly harmful clusters within adequately powered prospective cohort studies.</p></sec><sec id="Sec16"><title>Strengths and limitations of the study</title><p id="Par37">Our study relied on unique AF samples collected immediately before delivery by caesarean section under optimized conditions, excluding the contamination of the samples by the microbial spectrum and bacterial load of the maternal birth channel. Furthermore, we applied 16S rRNA gene-based sequencing to detect even low levels of bacterial genes, which is a well-described limitation of studies on this topic [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Further advances are that we did not have to rely on bacterial cultivation techniques that would have been hampered by the prenatal antibiotic treatment of the pregnancies with impending delivery or application immediately before delivery by caesarean section during clinical routine. But our study has limitations as well. There were some differences in baseline characteristics between the infants with and without severe outcomes. Due to the limited sample size, we were not able to apply, for example, propensity score matching to account for these disparities. But regression analyses did not detect interactions by birth weight as the most relevant confounder. And we recently showed for BPD on this cohort and now for ROP and the 2-year psychomotor outcome that when comparing disease severity stages, the disparity in baseline characteristics was no more pronounced, arguing for bacterial strain-specific effects and not changes in colonization during different gestational ages [<xref ref-type="bibr" rid="CR24">24</xref>]. We excluded a systematic bias by sample selection as samples from patients included and excluded for low bacterial reads did not differ in their baseline characteristics. Furthermore, the sample volumes were too small to expand the studies to long-read sequencing to specify the pathogenicity of the specific bacterial strains. The number of samples was limited due to the single-centre approach and the restricted time interval of sample collection. For this, further categorization beyond the morbidity level and to respect, for example, sex specific variations and the impact of variation in hygiene measures was not feasible [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. But as no changes in clinical treatment relevant to the study outcomes were introduced during the sample collection period and the frequencies of the severe outcomes did not change over time (data not shown), we can exclude the introduction of a systematic bias to the results. We cannot completely exclude skin bacterial contamination during caesarean deliveries, but samples were first obtained after opening of the uterus and skin commensals account for an average of 11% of reads in the samples. Furthermore, it remains a controversial discussion whether the AF harbours a vivid microbiome [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. It was not possible for us to verify bacterial viability, as perinatal antibiotic therapy during caesarean section is standard of care according to the guidelines in Germany. But the studies on <italic>Ureaplasma</italic> colonization in pregnancies with an intact amniotic membrane clearly indicate that the AF is not a sterile environment and that the rupture of membranes is not a prerequisite for bacterial invasion [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Sophisticated animal studies might help to prove the invasion of a vivid microbiome and the transmission of bacteria from other sites like the gut, oropharynx and further body niches as postulated in the available literature on this topic [<xref ref-type="bibr" rid="CR64">64</xref>&#x02013;<xref ref-type="bibr" rid="CR66">66</xref>]. The available literature on microbiota structures determined by 16&#x02009;s rRNA gene sequencing indicates changing risks with microbial dysbiosis [<xref ref-type="bibr" rid="CR67">67</xref>&#x02013;<xref ref-type="bibr" rid="CR69">69</xref>]. Our findings of microbiota structures in the AF of infants born preterm are in line with a recently published study that did find microbiota structures in pregnancies with an adverse outcome as well. Overall, the two studies give important insights into the microbiota dynamics in the amniotic fluid before and after the onset of labour [<xref ref-type="bibr" rid="CR70">70</xref>]. However, even if there is no vivid intra-amniotic microbiome, the detected bacterial 16S rRNA genes clearly indicate an association to the acute severe outcomes and the discrimination might be of relevance when considering that bacterial toxins like LPS are the primary executors of organ injury not only in the preterm infant [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Lastly, confirmation via qPCR absolute copy numbers would have been advantageous [<xref ref-type="bibr" rid="CR70">70</xref>]. Due to the small volumes of these unique samples, no material was left after quantification of bacterial load via 16S rRNA gene-based qPCR and sequencing; thus we were not able to do this additional analysis.</p></sec></sec><sec id="Sec17"><title>Conclusions</title><p id="Par38">The presented analyses specify the impact of the microbiota structures in the AF at birth on most of the acute severe outcomes of VPT birth and expand the associations far beyond the lung, while longer-term morbidities remained unchanged. The results are in line with previous observations that infants with BPD more frequently have a more severe respiratory course after birth and more frequently experience severe ROP [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR72">72</xref>&#x02013;<xref ref-type="bibr" rid="CR75">75</xref>]. While the scientific question is open whether severe morbidities like BPD predispose or cause further severe outcomes, the data from our actual analysis indicate that the acute and longer-term severe outcomes have at least overlapping, if not common, early origins of disease origination [<xref ref-type="bibr" rid="CR75">75</xref>&#x02013;<xref ref-type="bibr" rid="CR77">77</xref>]. And they indicate that the early origins are not based on the immaturity per se and that early disease drivers exist even before preterm delivery that have a relevant impact on the outcomes and severity of the morbidities in the preterm infant [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR77">77</xref>]. This opens an important aspect to direct future therapeutic strategies intended to prevent acute severe outcomes. It might be too late to intervene during the longitudinal course in the NICU or even immediately after birth, but understanding the pathologies of the prenatal conditions and how to optimize the actual therapeutic interventions like antibiotic therapy might open a more promising window for improving the relevant outcomes and to focus the strive for novel effective therapies. The results thereby have implications for many disease entities far beyond the neonatal period and to focus research efforts on the detection of the early disease origins and the earliest possible intervention.</p></sec><sec id="Sec118" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12916_2025_4259_MOESM1_ESM.pdf"><caption><p>Additional File 1: Additional Figures S1 &#x02013; S3. Additional Figure S1. - Differences in number of 16S rRNA gene copies and microbial abundance and community composition between blank controls and amniotic fluid samples. Additional Figure S2. - Rarefaction curve for amniotic fluid samples. Additional Figure S3. - Bacterial load quantified via 16S rRNA gene-based qPCR.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12916_2025_4259_MOESM2_ESM.xlsx"><caption><p>Additional File 2: Additional Tables S1 &#x02013; S3. Additional Table S1. - List of Amplicon sequence variants (ASV) detected in blanks. Additional Table S2. - Amplicon sequence variants (ASV) counts per sample before normalization. Additional Table S3. - Logistic regression with birth weight.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AF</term><def><p id="Par7">Amniotic fluid</p></def></def-item><def-item><term>ASV</term><def><p id="Par8">Amplicon sequence variant</p></def></def-item><def-item><term>BPD</term><def><p id="Par9">Bronchopulmonary dysplasia</p></def></def-item><def-item><term>IVH</term><def><p id="Par10">Intraventricular haemorrhage</p></def></def-item><def-item><term>LOI</term><def><p id="Par11">Late-onset infection</p></def></def-item><def-item><term>LPS</term><def><p id="Par12">Lipopolysaccharide</p></def></def-item><def-item><term>MDI</term><def><p id="Par13">Mental developmental index</p></def></def-item><def-item><term>NEC</term><def><p id="Par14">Necrotizing enterocolitis</p></def></def-item><def-item><term>NICU</term><def><p id="Par15">Neonatal intensive care unit</p></def></def-item><def-item><term>PDI</term><def><p id="Par16">Psychomotor developmental index</p></def></def-item><def-item><term>ROP</term><def><p id="Par17">Retinopathy of prematurity</p></def></def-item><def-item><term>SGA</term><def><p id="Par18">Small for gestational age</p></def></def-item><def-item><term>VPT</term><def><p id="Par19">Very preterm</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Birte Staude and Silvia Gschwendtner contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements
</title><p>We thank the parents of all infants included into the study for their consent to participate.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions
</title><p>Conceptualization, B.S., S.G., M.S., and H.E.; Methodology, S.G., M.S., and H.E.; Sample collection, B.S., T.F., F.O., T.K., and H.E.; Sample processing, S.G., S.K., and M.S.; Sequencing, S.G., S.K., and M.S.; Collection of patient data, B.S., T.F., F.O., and T.K.; Visualization, S.G.; Writing of the original draft, B.S., S.G., M.S., and H.E.; Writing, reviewing and editing, all authors; all authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. This study was supported by Clinical Research Unit KFO309/2. The sponsor had no role in the design of the study, data collection and analyses, execution, interpretation or writing of the study.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All sequence data of the study are deposited in the short read archive of NCBI and accession number PRJNA1260988.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par39">The study was conducted following the rules of the Declaration of Helsinki, was approved by the ethics committee of the Justus-Liebig-University of Gie&#x000df;en (Az 135/12) and registered at DRKS (DRKS00004600). Written informed consent was obtained from the parents of preterm infants and pregnant women intended for prenatal interventions after provision of oral and written information.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par40">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests
</title><p id="Par41">The authors declare no competing interests.
</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>J</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Jansson</surname><given-names>J</given-names></name><name><surname>Lynch</surname><given-names>SV</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name></person-group><article-title>Current understanding of the human microbiome</article-title><source>Nat Med</source><year>2018</year><volume>24</volume><fpage>392</fpage><lpage>400</lpage><?supplied-pmid 29634682?><pub-id pub-id-type="pmid">29634682</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Gilbert J, Blaser MJ, Caporaso JG, Jansson J, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24:392&#x02013;400.<pub-id pub-id-type="pmid">29634682</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>SV</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name></person-group><article-title>The human intestinal microbiome in health and disease</article-title><source>N Engl J Med</source><year>2016</year><volume>375</volume><fpage>2369</fpage><lpage>2379</lpage><?supplied-pmid 27974040?><pub-id pub-id-type="pmid">27974040</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375:2369&#x02013;79.<pub-id pub-id-type="pmid">27974040</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>de Vos</surname><given-names>WM</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name><name><surname>Van Hul</surname><given-names>M</given-names></name><name><surname>Cani</surname><given-names>PD</given-names></name></person-group><article-title>Gut microbiome and health: mechanistic insights</article-title><source>Gut</source><year>2022</year><volume>71</volume><fpage>1020</fpage><lpage>1032</lpage><?supplied-pmid 35105664?><pub-id pub-id-type="pmid">35105664</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020&#x02013;32.<pub-id pub-id-type="pmid">35105664</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanna</surname><given-names>S</given-names></name><name><surname>van Zuydam</surname><given-names>NR</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Kurilshikov</surname><given-names>A</given-names></name><name><surname>Vich Vila</surname><given-names>A</given-names></name><name><surname>V&#x000f5;sa</surname><given-names>U</given-names></name><etal/></person-group><article-title>Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases</article-title><source>Nat Genet</source><year>2019</year><volume>51</volume><fpage>600</fpage><lpage>605</lpage><?supplied-pmid 30778224?><pub-id pub-id-type="pmid">30778224</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, V&#x000f5;sa U, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019;51:600&#x02013;5.<pub-id pub-id-type="pmid">30778224</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Dabke</surname><given-names>K</given-names></name><name><surname>Hendrick</surname><given-names>G</given-names></name><name><surname>Devkota</surname><given-names>S</given-names></name></person-group><article-title>The gut microbiome and metabolic syndrome</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><fpage>4050</fpage><lpage>4057</lpage><?supplied-pmid 31573550?><pub-id pub-id-type="pmid">31573550</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019;129:4050&#x02013;7.<pub-id pub-id-type="pmid">31573550</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>TC</given-names></name><name><surname>Olson</surname><given-names>CA</given-names></name><name><surname>Hsiao</surname><given-names>EY</given-names></name></person-group><article-title>Interactions between the microbiota, immune and nervous systems in health and disease</article-title><source>Nat Neurosci</source><year>2017</year><volume>20</volume><fpage>145</fpage><lpage>155</lpage><?supplied-pmid 28092661?><pub-id pub-id-type="pmid">28092661</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20:145&#x02013;55.<pub-id pub-id-type="pmid">28092661</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Stiemsma</surname><given-names>LT</given-names></name><name><surname>Michels</surname><given-names>KB</given-names></name></person-group><article-title>The role of the microbiome in the developmental origins of health and disease</article-title><source>Pediatrics</source><year>2018</year><volume>141</volume><fpage>e20172437</fpage><?supplied-pmid 29519955?><pub-id pub-id-type="pmid">29519955</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Stiemsma LT, Michels KB. The role of the microbiome in the developmental origins of health and disease. Pediatrics. 2018;141: e20172437.<pub-id pub-id-type="pmid">29519955</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Kolodziejczyk</surname><given-names>AA</given-names></name><name><surname>Thaiss</surname><given-names>CA</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name></person-group><article-title>Dysbiosis and the immune system</article-title><source>Nat Rev Immunol</source><year>2017</year><volume>17</volume><fpage>219</fpage><lpage>232</lpage><?supplied-pmid 28260787?><pub-id pub-id-type="pmid">28260787</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17:219&#x02013;32.<pub-id pub-id-type="pmid">28260787</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Pattaroni</surname><given-names>C</given-names></name><name><surname>Watzenboeck</surname><given-names>ML</given-names></name><name><surname>Schneidegger</surname><given-names>S</given-names></name><name><surname>Kieser</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>NC</given-names></name><name><surname>Bernasconi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Early-life formation of the microbial and immunological environment of the human airways</article-title><source>Cell Host Microbe</source><year>2018</year><volume>24</volume><fpage>857</fpage><lpage>865.e4</lpage><?supplied-pmid 30503510?><pub-id pub-id-type="pmid">30503510</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Pattaroni C, Watzenboeck ML, Schneidegger S, Kieser S, Wong NC, Bernasconi E, et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe. 2018;24:857-865.e4.<pub-id pub-id-type="pmid">30503510</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>BG</given-names></name><name><surname>Sulaiman</surname><given-names>I</given-names></name><name><surname>Tsay</surname><given-names>J-CJ</given-names></name><name><surname>Perez</surname><given-names>L</given-names></name><name><surname>Franca</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae</article-title><source>Am J Respir Crit Care Med.</source><year>2021</year><volume>203</volume><fpage>1099</fpage><lpage>111</lpage><?supplied-pmid 33166473?><pub-id pub-id-type="pmid">33166473</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Wu BG, Sulaiman I, Tsay J-CJ, Perez L, Franca B, Li Y, et al. Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae. Am J Respir Crit Care Med. 2021;203:1099&#x02013;111.<pub-id pub-id-type="pmid">33166473</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Cyr-Depauw</surname><given-names>C</given-names></name><name><surname>Hurskainen</surname><given-names>M</given-names></name><name><surname>Vadivel</surname><given-names>A</given-names></name><name><surname>Mi&#x0017e;&#x000ed;kov&#x000e1;</surname><given-names>I</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Th&#x000e9;baud</surname><given-names>B</given-names></name></person-group><article-title>Characterization of the innate immune response in a novel murine model mimicking bronchopulmonary dysplasia</article-title><source>Pediatr Res</source><year>2021</year><volume>89</volume><fpage>803</fpage><lpage>813</lpage><?supplied-pmid 32434214?><pub-id pub-id-type="pmid">32434214</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Cyr-Depauw C, Hurskainen M, Vadivel A, Mi&#x0017e;&#x000ed;kov&#x000e1; I, Lesage F, Th&#x000e9;baud B. Characterization of the innate immune response in a novel murine model mimicking bronchopulmonary dysplasia. Pediatr Res. 2021;89:803&#x02013;13.<pub-id pub-id-type="pmid">32434214</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>B</given-names></name><name><surname>Peisl</surname><given-names>A</given-names></name><name><surname>Seedorf</surname><given-names>G</given-names></name><name><surname>Nowlin</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Bosco</surname><given-names>J</given-names></name><etal/></person-group><article-title>Anti&#x02013;sFlt-1 therapy preserves lung alveolar and vascular growth in antenatal models of bronchopulmonary dysplasia</article-title><source>Am J Respir Crit Care Med</source><year>2018</year><volume>197</volume><fpage>776</fpage><lpage>787</lpage><?supplied-pmid 29268623?><pub-id pub-id-type="pmid">29268623</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Wallace B, Peisl A, Seedorf G, Nowlin T, Kim C, Bosco J, et al. Anti&#x02013;sFlt-1 therapy preserves lung alveolar and vascular growth in antenatal models of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2018;197:776&#x02013;87.<pub-id pub-id-type="pmid">29268623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y</given-names></name><name><surname>Rivetti</surname><given-names>S</given-names></name><name><surname>Lingampally</surname><given-names>A</given-names></name><name><surname>Tacke</surname><given-names>S</given-names></name><name><surname>Kojonazarov</surname><given-names>B</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name><etal/></person-group><article-title>Insights into the black box of intra-amniotic infection and its impact on the premature lung: from clinical and preclinical perspectives</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><fpage>9792</fpage><?supplied-pmid 36077187?><pub-id pub-id-type="pmid">36077187</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Dong Y, Rivetti S, Lingampally A, Tacke S, Kojonazarov B, Bellusci S, et al. Insights into the black box of intra-amniotic infection and its impact on the premature lung: from clinical and preclinical perspectives. Int J Mol Sci. 2022;23:9792.<pub-id pub-id-type="pmid">36077187</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>DeMauro</surname><given-names>SB</given-names></name></person-group><article-title>Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia</article-title><source>Pediatr Pulmonol</source><year>2021</year><volume>56</volume><fpage>3509</fpage><lpage>3517</lpage><?supplied-pmid 33749169?><pub-id pub-id-type="pmid">33749169</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">DeMauro SB. Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56:3509&#x02013;17.<pub-id pub-id-type="pmid">33749169</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name></person-group><article-title>Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis</article-title><source>Eur J Pediatr</source><year>2024</year><volume>183</volume><fpage>3147</fpage><lpage>3158</lpage><?supplied-pmid 38684534?><pub-id pub-id-type="pmid">38684534</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wang Y, Liu S, Lu M, Huang T, Huang L. Neurodevelopmental outcomes of preterm with necrotizing enterocolitis: a systematic review and meta-analysis. Eur J Pediatr. 2024;183:3147&#x02013;58.<pub-id pub-id-type="pmid">38684534</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>BJ</given-names></name><name><surname>Hansen</surname><given-names>NI</given-names></name><name><surname>Adams-Chapman</surname><given-names>I</given-names></name><name><surname>Fanaroff</surname><given-names>AA</given-names></name><name><surname>Hintz</surname><given-names>SR</given-names></name><name><surname>Vohr</surname><given-names>B</given-names></name><etal/></person-group><article-title>Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection</article-title><source>JAMA</source><year>2004</year><volume>292</volume><fpage>2357</fpage><lpage>2365</lpage><?supplied-pmid 15547163?><pub-id pub-id-type="pmid">15547163</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357&#x02013;65.<pub-id pub-id-type="pmid">15547163</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Diggikar</surname><given-names>S</given-names></name><name><surname>Gurumoorthy</surname><given-names>P</given-names></name><name><surname>Trif</surname><given-names>P</given-names></name><name><surname>Mudura</surname><given-names>D</given-names></name><name><surname>Nagesh</surname><given-names>NK</given-names></name><name><surname>Galis</surname><given-names>R</given-names></name><etal/></person-group><article-title>Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: a systematic review and meta-analysis</article-title><source>Front Pediatr</source><year>2023</year><volume>11</volume><fpage>1055813</fpage><?supplied-pmid 37009271?><pub-id pub-id-type="pmid">37009271</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Diggikar S, Gurumoorthy P, Trif P, Mudura D, Nagesh NK, Galis R, et al. Retinopathy of prematurity and neurodevelopmental outcomes in preterm infants: a systematic review and meta-analysis. Front Pediatr. 2023;11:1055813.<pub-id pub-id-type="pmid">37009271</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Horbar</surname><given-names>JD</given-names></name><name><surname>Greenberg</surname><given-names>LT</given-names></name><name><surname>Buzas</surname><given-names>JS</given-names></name><name><surname>Ehret</surname><given-names>DEY</given-names></name><name><surname>Soll</surname><given-names>RF</given-names></name><name><surname>Edwards</surname><given-names>EM</given-names></name></person-group><article-title>Trends in mortality and morbidities for infants born 24 to 28 weeks in the US: 1997&#x02013;2021</article-title><source>Pediatrics</source><year>2024</year><volume>153</volume><fpage>e2023064153</fpage><?supplied-pmid 38053449?><pub-id pub-id-type="pmid">38053449</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Horbar JD, Greenberg LT, Buzas JS, Ehret DEY, Soll RF, Edwards EM. Trends in mortality and morbidities for infants born 24 to 28 weeks in the US: 1997&#x02013;2021. Pediatrics. 2024;153: e2023064153.<pub-id pub-id-type="pmid">38053449</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>HK</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Ko</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>CW</given-names></name><etal/></person-group><article-title>Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity</article-title><source>J Neuroinflammation</source><year>2014</year><volume>11</volume><fpage>87</fpage><?supplied-pmid 24886524?><pub-id pub-id-type="pmid">24886524</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Hong HK, Lee HJ, Ko JH, Park JH, Park JY, Choi CW, et al. Neonatal systemic inflammation in rats alters retinal vessel development and simulates pathologic features of retinopathy of prematurity. J Neuroinflammation. 2014;11:87.<pub-id pub-id-type="pmid">24886524</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>KC</given-names></name><name><surname>Del Moral</surname><given-names>T</given-names></name><name><surname>Claure</surname><given-names>N</given-names></name><name><surname>Vanbuskirk</surname><given-names>S</given-names></name><name><surname>Bancalari</surname><given-names>E</given-names></name></person-group><article-title>The association between early tracheal colonization and bronchopulmonary dysplasia</article-title><source>J Perinatol</source><year>2005</year><volume>25</volume><fpage>403</fpage><lpage>407</lpage><?supplied-pmid 15843814?><pub-id pub-id-type="pmid">15843814</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Young KC, Del Moral T, Claure N, Vanbuskirk S, Bancalari E. The association between early tracheal colonization and bronchopulmonary dysplasia. J Perinatol. 2005;25:403&#x02013;7.<pub-id pub-id-type="pmid">15843814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Lauer</surname><given-names>T</given-names></name><name><surname>Behnke</surname><given-names>J</given-names></name><name><surname>Oehmke</surname><given-names>F</given-names></name><name><surname>Baecker</surname><given-names>J</given-names></name><name><surname>Gentil</surname><given-names>K</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name><etal/></person-group><article-title>Bacterial colonization within the first six weeks of life and pulmonary outcome in preterm infants &#x0003c;1000 g</article-title><source>J Clin Med</source><year>2020</year><volume>9</volume><fpage>2240</fpage><?supplied-pmid 32679682?><pub-id pub-id-type="pmid">32679682</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Lauer T, Behnke J, Oehmke F, Baecker J, Gentil K, Chakraborty T, et al. Bacterial colonization within the first six weeks of life and pulmonary outcome in preterm infants &#x0003c;1000 g. J Clin Med. 2020;9:2240.<pub-id pub-id-type="pmid">32679682</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Pammi</surname><given-names>M</given-names></name><name><surname>Lal</surname><given-names>CV</given-names></name><name><surname>Wagner</surname><given-names>BD</given-names></name><name><surname>Mourani</surname><given-names>PM</given-names></name><name><surname>Lohmann</surname><given-names>P</given-names></name><name><surname>Luna</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Airway microbiome and development of bronchopulmonary dysplasia in preterm infants: a systematic review</article-title><source>J Pediatr</source><year>2019</year><volume>204</volume><fpage>126</fpage><lpage>133.e2</lpage><?supplied-pmid 30297287?><pub-id pub-id-type="pmid">30297287</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Pammi M, Lal CV, Wagner BD, Mourani PM, Lohmann P, Luna RA, et al. Airway microbiome and development of bronchopulmonary dysplasia in preterm infants: a systematic review. J Pediatr. 2019;204:126-133.e2.<pub-id pub-id-type="pmid">30297287</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Lal</surname><given-names>CV</given-names></name><name><surname>Kandasamy</surname><given-names>J</given-names></name><name><surname>Dolma</surname><given-names>K</given-names></name><name><surname>Ramani</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>L</given-names></name><etal/></person-group><article-title>Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2018</year><volume>315</volume><fpage>L810</fpage><lpage>L815</lpage><?supplied-pmid 30113227?><pub-id pub-id-type="pmid">30113227</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lal CV, Kandasamy J, Dolma K, Ramani M, Kumar R, Wilson L, et al. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2018;315:L810&#x02013;5.<pub-id pub-id-type="pmid">30113227</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Staude</surname><given-names>B</given-names></name><name><surname>Gschwendtner</surname><given-names>S</given-names></name><name><surname>Frodermann</surname><given-names>T</given-names></name><name><surname>Oehmke</surname><given-names>F</given-names></name><name><surname>Kohl</surname><given-names>T</given-names></name><name><surname>Kublik</surname><given-names>S</given-names></name><etal/></person-group><article-title>Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia</article-title><source>Respir Res</source><year>2023</year><volume>24</volume><fpage>248</fpage><?supplied-pmid 37845700?><pub-id pub-id-type="pmid">37845700</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Staude B, Gschwendtner S, Frodermann T, Oehmke F, Kohl T, Kublik S, et al. Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia. Respir Res. 2023;24:248.<pub-id pub-id-type="pmid">37845700</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;rtel</surname><given-names>C</given-names></name><name><surname>Herting</surname><given-names>E</given-names></name><name><surname>Humberg</surname><given-names>A</given-names></name><name><surname>Hanke</surname><given-names>K</given-names></name><name><surname>Mehler</surname><given-names>K</given-names></name><name><surname>Keller</surname><given-names>T</given-names></name><etal/></person-group><article-title>Association of administration of surfactant using less invasive methods with outcomes in extremely preterm infants less than 27 weeks of gestation</article-title><source>JAMA Netw Open</source><year>2022</year><volume>5</volume><fpage>e2225810</fpage><?supplied-pmid 35943742?><pub-id pub-id-type="pmid">35943742</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">H&#x000e4;rtel C, Herting E, Humberg A, Hanke K, Mehler K, Keller T, et al. Association of administration of surfactant using less invasive methods with outcomes in extremely preterm infants less than 27 weeks of gestation. JAMA Netw Open. 2022;5: e2225810.<pub-id pub-id-type="pmid">35943742</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Dargaville</surname><given-names>PA</given-names></name><name><surname>Kamlin</surname><given-names>COF</given-names></name><name><surname>Orsini</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>De Paoli</surname><given-names>AG</given-names></name><name><surname>Kanmaz Kutman</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome</article-title><source>JAMA</source><year>2021</year><volume>326</volume><fpage>1</fpage><lpage>10</lpage></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. JAMA. 2021;326:1&#x02013;10.</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Schulman</surname><given-names>J</given-names></name><name><surname>Stricof</surname><given-names>R</given-names></name><name><surname>Stevens</surname><given-names>TP</given-names></name><name><surname>Horgan</surname><given-names>M</given-names></name><name><surname>Gase</surname><given-names>K</given-names></name><name><surname>Holzman</surname><given-names>IR</given-names></name><etal/></person-group><article-title>Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists</article-title><source>Pediatrics</source><year>2011</year><volume>127</volume><fpage>436</fpage><lpage>444</lpage><?supplied-pmid 21339265?><pub-id pub-id-type="pmid">21339265</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Schulman J, Stricof R, Stevens TP, Horgan M, Gase K, Holzman IR, et al. Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists. Pediatrics. 2011;127:436&#x02013;44.<pub-id pub-id-type="pmid">21339265</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Colaizy</surname><given-names>TT</given-names></name><name><surname>Poindexter</surname><given-names>BB</given-names></name><name><surname>McDonald</surname><given-names>SA</given-names></name><name><surname>Bell</surname><given-names>EF</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Carlson</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Neurodevelopmental outcomes of extremely preterm infants fed donor milk or preterm infant formula: a randomized clinical trial</article-title><source>JAMA</source><year>2024</year><volume>331</volume><fpage>582</fpage><lpage>591</lpage><?supplied-pmid 38497706?><pub-id pub-id-type="pmid">38497706</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Colaizy TT, Poindexter BB, McDonald SA, Bell EF, Carlo WA, Carlson SJ, et al. Neurodevelopmental outcomes of extremely preterm infants fed donor milk or preterm infant formula: a randomized clinical trial. JAMA. 2024;331:582&#x02013;91.<pub-id pub-id-type="pmid">38497706</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Behnke</surname><given-names>J</given-names></name><name><surname>Estreich</surname><given-names>V</given-names></name><name><surname>Oehmke</surname><given-names>F</given-names></name><name><surname>Zimmer</surname><given-names>K-P</given-names></name><name><surname>Windhorst</surname><given-names>A</given-names></name><name><surname>Ehrhardt</surname><given-names>H</given-names></name></person-group><article-title>Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants&#x02014;an observational study</article-title><source>Pediatr Pulmonol</source><year>2022</year><volume>57</volume><fpage>1117</fpage><lpage>1126</lpage><?supplied-pmid 35191216?><pub-id pub-id-type="pmid">35191216</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Behnke J, Estreich V, Oehmke F, Zimmer K-P, Windhorst A, Ehrhardt H. Compatibility of rapid enteral feeding advances and noninvasive ventilation in preterm infants&#x02014;an observational study. Pediatr Pulmonol. 2022;57:1117&#x02013;26.<pub-id pub-id-type="pmid">35191216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Voigt</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>KTM</given-names></name><name><surname>J&#x000e4;hrig</surname><given-names>K</given-names></name></person-group><article-title>Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland [Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body weight of newborn infants]</article-title><source>Geburtshilfe Frauenheilkd</source><year>1996</year><volume>56</volume><fpage>550</fpage><lpage>558</lpage><?supplied-pmid 9036070?><pub-id pub-id-type="pmid">9036070</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Voigt M, Schneider KTM, J&#x000e4;hrig K. Analyse des Geburtengutes des Jahrgangs 1992 der Bundesrepublik Deutschland [Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body weight of newborn infants]. Geburtshilfe Frauenheilkd. 1996;56:550&#x02013;8.<pub-id pub-id-type="pmid">9036070</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Jobe</surname><given-names>AH</given-names></name><name><surname>Bancalari</surname><given-names>E</given-names></name></person-group><article-title>Bronchopulmonary dysplasia</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>1723</fpage><lpage>1729</lpage><?supplied-pmid 11401896?><pub-id pub-id-type="pmid">11401896</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723&#x02013;9.<pub-id pub-id-type="pmid">11401896</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>DJ</given-names></name><name><surname>Andersen</surname><given-names>CC</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Holberton</surname><given-names>J</given-names></name></person-group><article-title>Pharyngeal pressure with high-flow nasal cannulae in premature infants</article-title><source>J Perinatol</source><year>2008</year><volume>28</volume><fpage>42</fpage><lpage>47</lpage><?supplied-pmid 17989697?><pub-id pub-id-type="pmid">17989697</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wilkinson DJ, Andersen CC, Smith K, Holberton J. Pharyngeal pressure with high-flow nasal cannulae in premature infants. J Perinatol. 2008;28:42&#x02013;7.<pub-id pub-id-type="pmid">17989697</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>M</given-names></name><name><surname>Engle</surname><given-names>W</given-names></name><name><surname>Laptook</surname><given-names>A</given-names></name><name><surname>Kazzi</surname><given-names>SNJ</given-names></name><name><surname>Buchter</surname><given-names>S</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Oxygen delivery through nasal cannulae to preterm infants: can practice be improved?</article-title><source>Pediatrics</source><year>2005</year><volume>116</volume><fpage>857</fpage><lpage>861</lpage><?supplied-pmid 16199694?><pub-id pub-id-type="pmid">16199694</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Walsh M, Engle W, Laptook A, Kazzi SNJ, Buchter S, Rasmussen M, et al. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005;116:857&#x02013;61.<pub-id pub-id-type="pmid">16199694</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Deeg</surname><given-names>KH</given-names></name><name><surname>Staudt</surname><given-names>F</given-names></name></person-group><article-title>von Rohden L [Classification of intracranial hemorrhage in premature infants]</article-title><source>Ultraschall Med</source><year>1999</year><volume>20</volume><fpage>165</fpage><lpage>170</lpage><?supplied-pmid 10522360?><pub-id pub-id-type="pmid">10522360</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Deeg KH, Staudt F. von Rohden L [Classification of intracranial hemorrhage in premature infants]. Ultraschall Med. 1999;20:165&#x02013;70.<pub-id pub-id-type="pmid">10522360</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Leistner</surname><given-names>R</given-names></name><name><surname>Piening</surname><given-names>B</given-names></name><name><surname>Gastmeier</surname><given-names>P</given-names></name><name><surname>Geffers</surname><given-names>C</given-names></name><name><surname>Schwab</surname><given-names>F</given-names></name></person-group><article-title>Nosocomial infections in very low birthweight infants in Germany: current data from the National Surveillance System NEO-KISS</article-title><source>Klin Padiatr</source><year>2013</year><volume>225</volume><fpage>75</fpage><lpage>80</lpage><?supplied-pmid 23526612?><pub-id pub-id-type="pmid">23526612</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Leistner R, Piening B, Gastmeier P, Geffers C, Schwab F. Nosocomial infections in very low birthweight infants in Germany: current data from the National Surveillance System NEO-KISS. Klin Padiatr. 2013;225:75&#x02013;80.<pub-id pub-id-type="pmid">23526612</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>AR</given-names></name><name><surname>Engel</surname><given-names>C</given-names></name><name><surname>Bassler</surname><given-names>D</given-names></name><name><surname>R&#x000fc;diger</surname><given-names>M</given-names></name><name><surname>Thome</surname><given-names>UH</given-names></name><name><surname>Maier</surname><given-names>RF</given-names></name><etal/></person-group><article-title>Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial</article-title><source>JAMA</source><year>2020</year><volume>324</volume><fpage>560</fpage><lpage>570</lpage><?supplied-pmid 32780138?><pub-id pub-id-type="pmid">32780138</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Franz AR, Engel C, Bassler D, R&#x000fc;diger M, Thome UH, Maier RF, et al. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial. JAMA. 2020;324:560&#x02013;70.<pub-id pub-id-type="pmid">32780138</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheong</surname><given-names>JLY</given-names></name><name><surname>Olsen</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>KJ</given-names></name><name><surname>Spittle</surname><given-names>AJ</given-names></name><name><surname>Opie</surname><given-names>GF</given-names></name><name><surname>Clark</surname><given-names>M</given-names></name><etal/></person-group><article-title>Temporal trends in neurodevelopmental outcomes to 2 years after extremely preterm birth</article-title><source>JAMA Pediatr</source><year>2021</year><volume>175</volume><fpage>1035</fpage><lpage>1042</lpage><?supplied-pmid 34279561?><pub-id pub-id-type="pmid">34279561</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Cheong JLY, Olsen JE, Lee KJ, Spittle AJ, Opie GF, Clark M, et al. Temporal trends in neurodevelopmental outcomes to 2 years after extremely preterm birth. JAMA Pediatr. 2021;175:1035&#x02013;42.<pub-id pub-id-type="pmid">34279561</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Lueders</surname><given-names>T</given-names></name><name><surname>Manefield</surname><given-names>M</given-names></name><name><surname>Friedrich</surname><given-names>MW</given-names></name></person-group><article-title>Enhanced sensitivity of DNA- and rRNA-based stable isotope probing by fractionation and quantitative analysis of isopycnic centrifugation gradients</article-title><source>Environ Microbiol</source><year>2004</year><volume>6</volume><fpage>73</fpage><lpage>78</lpage><?supplied-pmid 14686943?><pub-id pub-id-type="pmid">14686943</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lueders T, Manefield M, Friedrich MW. Enhanced sensitivity of DNA- and rRNA-based stable isotope probing by fractionation and quantitative analysis of isopycnic centrifugation gradients. Environ Microbiol. 2004;6:73&#x02013;8.<pub-id pub-id-type="pmid">14686943</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Nossa</surname><given-names>CW</given-names></name><name><surname>Oberdorf</surname><given-names>WE</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Aas</surname><given-names>JA</given-names></name><name><surname>Paster</surname><given-names>BJ</given-names></name><name><surname>DeSantis</surname><given-names>TZ</given-names></name><etal/></person-group><article-title>Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome</article-title><source>World J Gastroenterol</source><year>2010</year><volume>16</volume><fpage>4135</fpage><lpage>4144</lpage><?supplied-pmid 20806429?><pub-id pub-id-type="pmid">20806429</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Nossa CW, Oberdorf WE, Yang L, Aas JA, Paster BJ, DeSantis TZ, et al. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol. 2010;16:4135&#x02013;44.<pub-id pub-id-type="pmid">20806429</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>JG</given-names></name><name><surname>Kuczynski</surname><given-names>J</given-names></name><name><surname>Stombaugh</surname><given-names>J</given-names></name><name><surname>Bittinger</surname><given-names>K</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>Costello</surname><given-names>EK</given-names></name><etal/></person-group><article-title>QIIME allows analysis of high-throughput community sequencing data</article-title><source>Nat Methods</source><year>2010</year><volume>7</volume><fpage>335</fpage><lpage>336</lpage><?supplied-pmid 20383131?><pub-id pub-id-type="pmid">20383131</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335&#x02013;6.<pub-id pub-id-type="pmid">20383131</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>BJ</given-names></name><name><surname>McMurdie</surname><given-names>PJ</given-names></name><name><surname>Rosen</surname><given-names>MJ</given-names></name><name><surname>Han</surname><given-names>AW</given-names></name><name><surname>Johnson</surname><given-names>AJA</given-names></name><name><surname>Holmes</surname><given-names>SP</given-names></name></person-group><article-title>DADA2: high-resolution sample inference from Illumina amplicon data</article-title><source>Nat Methods</source><year>2016</year><volume>13</volume><fpage>581</fpage><lpage>583</lpage><?supplied-pmid 27214047?><pub-id pub-id-type="pmid">27214047</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581&#x02013;3.<pub-id pub-id-type="pmid">27214047</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenblad</surname><given-names>AJJ</given-names></name></person-group><article-title>Faraway: Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models</article-title><source>Comput Stat</source><year>2009</year><volume>24</volume><fpage>369</fpage><lpage>370</lpage></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Rosenblad AJJ. Faraway: Extending the linear model with R: generalized linear, mixed effects and nonparametric regression models. Comput Stat. 2009;24:369&#x02013;70.</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Gallacher D, Mitchell E, Alber D, Wach R, Klein N, Marchesi JR, et al. Dissimilarity of the gut&#x02013;lung axis and dysbiosis of the lower airways in ventilated preterm infants. Eur Respir J. 2020;55:1901909.</mixed-citation></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Usuda</surname><given-names>H</given-names></name><name><surname>Carter</surname><given-names>S</given-names></name><name><surname>Fee</surname><given-names>EL</given-names></name><name><surname>Furfaro</surname><given-names>L</given-names></name><etal/></person-group><article-title>Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheep</article-title><source>Am J Obstet Gynecol MFM</source><year>2023</year><volume>5</volume><fpage>101124</fpage><?supplied-pmid 37597799?><pub-id pub-id-type="pmid">37597799</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Takahashi Y, Takahashi T, Usuda H, Carter S, Fee EL, Furfaro L, et al. Pharmacological blockade of the interleukin-1 receptor suppressed Escherichia coli lipopolysaccharide-induced neuroinflammation in preterm fetal sheep. Am J Obstet Gynecol MFM. 2023;5: 101124.<pub-id pub-id-type="pmid">37597799</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>S</given-names></name><name><surname>Miloudi</surname><given-names>K</given-names></name><name><surname>Chaychi</surname><given-names>S</given-names></name><name><surname>Favret</surname><given-names>S</given-names></name><name><surname>Binet</surname><given-names>F</given-names></name><name><surname>Polosa</surname><given-names>A</given-names></name><etal/></person-group><article-title>Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function</article-title><source>Invest Ophthalmol Vis Sci</source><year>2013</year><volume>54</volume><fpage>8125</fpage><lpage>8139</lpage><?supplied-pmid 24204040?><pub-id pub-id-type="pmid">24204040</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Tremblay S, Miloudi K, Chaychi S, Favret S, Binet F, Polosa A, et al. Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci. 2013;54:8125&#x02013;39.<pub-id pub-id-type="pmid">24204040</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Sentenac</surname><given-names>M</given-names></name><name><surname>Benhammou</surname><given-names>V</given-names></name><name><surname>Aden</surname><given-names>U</given-names></name><name><surname>Ancel</surname><given-names>P-Y</given-names></name><name><surname>Bakker</surname><given-names>LA</given-names></name><name><surname>Bakoy</surname><given-names>H</given-names></name><etal/></person-group><article-title>Maternal education and cognitive development in 15 European very-preterm birth cohorts from the RECAP Preterm platform</article-title><source>Int J Epidemiol</source><year>2022</year><volume>50</volume><fpage>1824</fpage><lpage>1839</lpage><?supplied-pmid 34999864?><pub-id pub-id-type="pmid">34999864</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Sentenac M, Benhammou V, Aden U, Ancel P-Y, Bakker LA, Bakoy H, et al. Maternal education and cognitive development in 15 European very-preterm birth cohorts from the RECAP Preterm platform. Int J Epidemiol. 2022;50:1824&#x02013;39.<pub-id pub-id-type="pmid">34999864</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Sepp&#x000e4;nen</surname><given-names>A-V</given-names></name><name><surname>Draper</surname><given-names>ES</given-names></name><name><surname>Petrou</surname><given-names>S</given-names></name><name><surname>Barros</surname><given-names>H</given-names></name><name><surname>Andronis</surname><given-names>L</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Follow-up after very preterm birth in Europe</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2022</year><volume>107</volume><fpage>113</fpage><lpage>114</lpage><?supplied-pmid 33568495?><pub-id pub-id-type="pmid">33568495</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Sepp&#x000e4;nen A-V, Draper ES, Petrou S, Barros H, Andronis L, Kim SW, et al. Follow-up after very preterm birth in Europe. Arch Dis Child Fetal Neonatal Ed. 2022;107:113&#x02013;4.<pub-id pub-id-type="pmid">33568495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrhardt</surname><given-names>H</given-names></name><name><surname>Aubert</surname><given-names>AM</given-names></name><name><surname>&#x000c5;d&#x000e9;n</surname><given-names>U</given-names></name><name><surname>Draper</surname><given-names>ES</given-names></name><name><surname>Gudmundsdottir</surname><given-names>A</given-names></name><name><surname>Varendi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Apgar score and neurodevelopmental outcomes at age 5 years in infants born extremely preterm</article-title><source>JAMA Netw Open</source><year>2023</year><volume>6</volume><fpage>e2332413</fpage><?supplied-pmid 37672271?><pub-id pub-id-type="pmid">37672271</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Ehrhardt H, Aubert AM, &#x000c5;d&#x000e9;n U, Draper ES, Gudmundsdottir A, Varendi H, et al. Apgar score and neurodevelopmental outcomes at age 5 years in infants born extremely preterm. JAMA Netw Open. 2023;6: e2332413.<pub-id pub-id-type="pmid">37672271</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Cnattingius</surname><given-names>S</given-names></name><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Razaz</surname><given-names>N</given-names></name></person-group><article-title>Apgar score and risk of neonatal death among preterm infants</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><fpage>49</fpage><lpage>57</lpage><?supplied-pmid 32609981?><pub-id pub-id-type="pmid">32609981</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Cnattingius S, Johansson S, Razaz N. Apgar score and risk of neonatal death among preterm infants. N Engl J Med. 2020;383:49&#x02013;57.<pub-id pub-id-type="pmid">32609981</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>PS</given-names></name><name><surname>Norman</surname><given-names>M</given-names></name><name><surname>Rusconi</surname><given-names>F</given-names></name><name><surname>Kusuda</surname><given-names>S</given-names></name><name><surname>Reichman</surname><given-names>B</given-names></name><name><surname>Battin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Five-minute Apgar score and outcomes in neonates of 24&#x02013;28 weeks&#x02019; gestation</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>2022</year><volume>107</volume><fpage>437</fpage><lpage>446</lpage><?supplied-pmid 34782368?><pub-id pub-id-type="pmid">34782368</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Shah PS, Norman M, Rusconi F, Kusuda S, Reichman B, Battin M, et al. Five-minute Apgar score and outcomes in neonates of 24&#x02013;28 weeks&#x02019; gestation. Arch Dis Child Fetal Neonatal Ed. 2022;107:437&#x02013;46.<pub-id pub-id-type="pmid">34782368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Salmon F, Kayem G, Maisonneuve E, Foix-L&#x02019;H&#x000e9;lias L, Benhammou V, Kaminski M, et al. Clinical chorioamnionitis and neurodevelopment at 5 years of age in children born preterm: the EPIPAGE-2 cohort study. J Pediatr. 2024;267.</mixed-citation></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Glaser</surname><given-names>K</given-names></name><name><surname>Jensen</surname><given-names>EA</given-names></name><name><surname>Wright</surname><given-names>CJ</given-names></name></person-group><article-title>Prevention of inflammatory disorders in the preterm neonate: an update with a special focus on bronchopulmonary dysplasia</article-title><source>Neonatology</source><year>2024</year><volume>121</volume><fpage>636</fpage><lpage>645</lpage><?supplied-pmid 38870912?><pub-id pub-id-type="pmid">38870912</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Glaser K, Jensen EA, Wright CJ. Prevention of inflammatory disorders in the preterm neonate: an update with a special focus on bronchopulmonary dysplasia. Neonatology. 2024;121:636&#x02013;45.<pub-id pub-id-type="pmid">38870912</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Puopolo</surname><given-names>KM</given-names></name><name><surname>Hansen</surname><given-names>NI</given-names></name><name><surname>Lorch</surname><given-names>SA</given-names></name><name><surname>DeMauro</surname><given-names>SB</given-names></name><name><surname>Greenberg</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Impact of early-onset sepsis and antibiotic use on death or survival with neurodevelopmental impairment at 2 years of age among extremely preterm infants</article-title><source>J Pediatr</source><year>2020</year><volume>221</volume><fpage>39</fpage><lpage>46.e5</lpage><?supplied-pmid 32446491?><pub-id pub-id-type="pmid">32446491</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Mukhopadhyay S, Puopolo KM, Hansen NI, Lorch SA, DeMauro SB, Greenberg RG, et al. Impact of early-onset sepsis and antibiotic use on death or survival with neurodevelopmental impairment at 2 years of age among extremely preterm infants. J Pediatr. 2020;221:39-46.e5.<pub-id pub-id-type="pmid">32446491</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Behnke</surname><given-names>J</given-names></name><name><surname>Dippel</surname><given-names>CM</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Rekers</surname><given-names>L</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Lauer</surname><given-names>T</given-names></name><etal/></person-group><article-title>Oxygen toxicity to the immature lung&#x02014;part ii: the unmet clinical need for causal therapy</article-title><source>Int J Mol Sci</source><year>2021</year><volume>22</volume><fpage>10694</fpage><?supplied-pmid 34639034?><pub-id pub-id-type="pmid">34639034</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Behnke J, Dippel CM, Choi Y, Rekers L, Schmidt A, Lauer T, et al. Oxygen toxicity to the immature lung&#x02014;part ii: the unmet clinical need for causal therapy. Int J Mol Sci. 2021;22:10694.<pub-id pub-id-type="pmid">34639034</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Pruski</surname><given-names>P</given-names></name><name><surname>Correia</surname><given-names>GDS</given-names></name><name><surname>Lewis</surname><given-names>HV</given-names></name><name><surname>Capuccini</surname><given-names>K</given-names></name><name><surname>Inglese</surname><given-names>P</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><etal/></person-group><article-title>Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><fpage>5967</fpage><?supplied-pmid 34645809?><pub-id pub-id-type="pmid">34645809</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Pruski P, Correia GDS, Lewis HV, Capuccini K, Inglese P, Chan D, et al. Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth. Nat Commun. 2021;12:5967.<pub-id pub-id-type="pmid">34645809</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Polglase</surname><given-names>GR</given-names></name><name><surname>Dalton</surname><given-names>RGB</given-names></name><name><surname>Nitsos</surname><given-names>I</given-names></name><name><surname>Knox</surname><given-names>CL</given-names></name><name><surname>Pillow</surname><given-names>JJ</given-names></name><name><surname>Jobe</surname><given-names>AH</given-names></name><etal/></person-group><article-title>Pulmonary vascular and alveolar development in preterm lambs chronically colonized with Ureaplasma parvum</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2010</year><volume>299</volume><fpage>L232</fpage><lpage>241</lpage><?supplied-pmid 20495079?><pub-id pub-id-type="pmid">20495079</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Polglase GR, Dalton RGB, Nitsos I, Knox CL, Pillow JJ, Jobe AH, et al. Pulmonary vascular and alveolar development in preterm lambs chronically colonized with Ureaplasma parvum. Am J Physiol Lung Cell Mol Physiol. 2010;299:L232-241.<pub-id pub-id-type="pmid">20495079</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Kallapur</surname><given-names>SG</given-names></name><name><surname>Kramer</surname><given-names>BW</given-names></name><name><surname>Knox</surname><given-names>CL</given-names></name><name><surname>Berry</surname><given-names>CA</given-names></name><name><surname>Collins</surname><given-names>JJP</given-names></name><name><surname>Kemp</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep</article-title><source>J Immunol</source><year>2011</year><volume>187</volume><fpage>2688</fpage><lpage>2695</lpage><?supplied-pmid 21784974?><pub-id pub-id-type="pmid">21784974</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Kallapur SG, Kramer BW, Knox CL, Berry CA, Collins JJP, Kemp MW, et al. Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep. J Immunol. 2011;187:2688&#x02013;95.<pub-id pub-id-type="pmid">21784974</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Staude</surname><given-names>B</given-names></name><name><surname>Misselwitz</surname><given-names>B</given-names></name><name><surname>Louwen</surname><given-names>F</given-names></name><name><surname>Rochwalsky</surname><given-names>U</given-names></name><name><surname>Oehmke</surname><given-names>F</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>S</given-names></name><etal/></person-group><article-title>Characteristics and rates of preterm births during the COVID-19 pandemic in Germany</article-title><source>JAMA Netw Open</source><year>2024</year><volume>7</volume><fpage>e2432438</fpage><?supplied-pmid 39254973?><pub-id pub-id-type="pmid">39254973</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Staude B, Misselwitz B, Louwen F, Rochwalsky U, Oehmke F, K&#x000f6;hler S, et al. Characteristics and rates of preterm births during the COVID-19 pandemic in Germany. JAMA Netw Open. 2024;7: e2432438.<pub-id pub-id-type="pmid">39254973</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>JD</given-names></name><name><surname>Kielt</surname><given-names>MJ</given-names></name><name><surname>Conroy</surname><given-names>S</given-names></name><name><surname>Lingappan</surname><given-names>K</given-names></name><name><surname>Austin</surname><given-names>ED</given-names></name><name><surname>Eldredge</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Exploring the association of male sex with adverse outcomes in severe bronchopulmonary dysplasia: a retrospective, multicenter cohort study</article-title><source>Chest</source><year>2024</year><volume>165</volume><fpage>610</fpage><lpage>620</lpage><?supplied-pmid 37879559?><pub-id pub-id-type="pmid">37879559</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Hammond JD, Kielt MJ, Conroy S, Lingappan K, Austin ED, Eldredge LC, et al. Exploring the association of male sex with adverse outcomes in severe bronchopulmonary dysplasia: a retrospective, multicenter cohort study. Chest. 2024;165:610&#x02013;20.<pub-id pub-id-type="pmid">37879559</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Blaser</surname><given-names>MJ</given-names></name><name><surname>Devkota</surname><given-names>S</given-names></name><name><surname>McCoy</surname><given-names>KD</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Yassour</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>VB</given-names></name></person-group><article-title>Lessons learned from the prenatal microbiome controversy</article-title><source>Microbiome</source><year>2021</year><volume>9</volume><fpage>8</fpage><?supplied-pmid 33436098?><pub-id pub-id-type="pmid">33436098</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Blaser MJ, Devkota S, McCoy KD, Relman DA, Yassour M, Young VB. Lessons learned from the prenatal microbiome controversy. Microbiome. 2021;9:8.<pub-id pub-id-type="pmid">33436098</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>de Goffau</surname><given-names>MC</given-names></name><name><surname>Lager</surname><given-names>S</given-names></name><name><surname>Sovio</surname><given-names>U</given-names></name><name><surname>Gaccioli</surname><given-names>F</given-names></name><name><surname>Cook</surname><given-names>E</given-names></name><name><surname>Peacock</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Human placenta has no microbiome but can contain potential pathogens</article-title><source>Nature</source><year>2019</year><volume>572</volume><fpage>329</fpage><lpage>334</lpage><?supplied-pmid 31367035?><pub-id pub-id-type="pmid">31367035</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">de Goffau MC, Lager S, Sovio U, Gaccioli F, Cook E, Peacock SJ, et al. Human placenta has no microbiome but can contain potential pathogens. Nature. 2019;572:329&#x02013;34.<pub-id pub-id-type="pmid">31367035</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Nomiyama</surname><given-names>M</given-names></name><name><surname>Oshima</surname><given-names>Y</given-names></name><name><surname>Ono</surname><given-names>T</given-names></name><name><surname>Kozuma</surname><given-names>Y</given-names></name><name><surname>Nakura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Prenatal exposure to intra-amniotic infection with Ureaplasma species increases the prevalence of bronchopulmonary dysplasia</article-title><source>J Matern Fetal Neonatal Med</source><year>2024</year><volume>37</volume><fpage>2320670</fpage><?supplied-pmid 38418200?><pub-id pub-id-type="pmid">38418200</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Yamamoto T, Nomiyama M, Oshima Y, Ono T, Kozuma Y, Nakura Y, et al. Prenatal exposure to intra-amniotic infection with Ureaplasma species increases the prevalence of bronchopulmonary dysplasia. J Matern Fetal Neonatal Med. 2024;37:2320670.<pub-id pub-id-type="pmid">38418200</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Mittal Green</surname><given-names>P</given-names></name><name><surname>Nhan-Chang</surname><given-names>C-L</given-names></name><name><surname>Vaisbuch</surname><given-names>E</given-names></name><etal/></person-group><article-title>Characterization of amniotic fluid sludge in preterm and term gestations</article-title><source>J Matern Fetal Neonatal Med</source><year>2022</year><volume>35</volume><fpage>9770</fpage><lpage>9779</lpage><?supplied-pmid 35341439?><pub-id pub-id-type="pmid">35341439</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Kusanovic JP, Jung E, Romero R, Mittal Green P, Nhan-Chang C-L, Vaisbuch E, et al. Characterization of amniotic fluid sludge in preterm and term gestations. J Matern Fetal Neonatal Med. 2022;35:9770&#x02013;9.<pub-id pub-id-type="pmid">35341439</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Hosang</surname><given-names>L</given-names></name><name><surname>Canals</surname><given-names>RC</given-names></name><name><surname>van der Flier</surname><given-names>FJ</given-names></name><name><surname>Hollensteiner</surname><given-names>J</given-names></name><name><surname>Daniel</surname><given-names>R</given-names></name><name><surname>Fl&#x000fc;gel</surname><given-names>A</given-names></name><etal/></person-group><article-title>The lung microbiome regulates brain autoimmunity</article-title><source>Nature</source><year>2022</year><volume>603</volume><fpage>138</fpage><lpage>144</lpage><?supplied-pmid 35197636?><pub-id pub-id-type="pmid">35197636</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Hosang L, Canals RC, van der Flier FJ, Hollensteiner J, Daniel R, Fl&#x000fc;gel A, et al. The lung microbiome regulates brain autoimmunity. Nature. 2022;603:138&#x02013;44.<pub-id pub-id-type="pmid">35197636</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Argaw-Denboba</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>TSB</given-names></name><name><surname>Di Giacomo</surname><given-names>M</given-names></name><name><surname>Ranjan</surname><given-names>B</given-names></name><name><surname>Devendran</surname><given-names>S</given-names></name><name><surname>Mastrorilli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Paternal microbiome perturbations impact offspring fitness</article-title><source>Nature</source><year>2024</year><volume>629</volume><fpage>652</fpage><lpage>659</lpage><?supplied-pmid 38693261?><pub-id pub-id-type="pmid">38693261</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Argaw-Denboba A, Schmidt TSB, Di Giacomo M, Ranjan B, Devendran S, Mastrorilli E, et al. Paternal microbiome perturbations impact offspring fitness. Nature. 2024;629:652&#x02013;9.<pub-id pub-id-type="pmid">38693261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Staude</surname><given-names>B</given-names></name><name><surname>Oehmke</surname><given-names>F</given-names></name><name><surname>Lauer</surname><given-names>T</given-names></name><name><surname>Behnke</surname><given-names>J</given-names></name><name><surname>G&#x000f6;pel</surname><given-names>W</given-names></name><name><surname>Schloter</surname><given-names>M</given-names></name><etal/></person-group><article-title>The microbiome and preterm birth: a change in paradigm with profound implications for pathophysiologic concepts and novel therapeutic strategies</article-title><source>Biomed Res Int</source><year>2018</year><volume>2018</volume><fpage>7218187</fpage><?supplied-pmid 30370305?><pub-id pub-id-type="pmid">30370305</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Staude B, Oehmke F, Lauer T, Behnke J, G&#x000f6;pel W, Schloter M, et al. The microbiome and preterm birth: a change in paradigm with profound implications for pathophysiologic concepts and novel therapeutic strategies. Biomed Res Int. 2018;2018:7218187.<pub-id pub-id-type="pmid">30370305</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Miranda</surname><given-names>J</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes</article-title><source>J Matern Fetal Neonatal Med</source><year>2015</year><volume>28</volume><fpage>1394</fpage><lpage>1409</lpage><?supplied-pmid 25190175?><pub-id pub-id-type="pmid">25190175</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2015;28:1394&#x02013;409.<pub-id pub-id-type="pmid">25190175</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhong</surname><given-names>J</given-names></name><etal/></person-group><article-title>Prolonged premature rupture of membranes with increased risk of infection is associated with gut accumulation of Pseudomonas from the environment</article-title><source>Comput Struct Biotechnol J</source><year>2024</year><volume>23</volume><fpage>2851</fpage><lpage>2860</lpage><?supplied-pmid 39100803?><pub-id pub-id-type="pmid">39100803</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Xiang Q, Yan X, Shi X, Huang Y, Li L, Zhong J, et al. Prolonged premature rupture of membranes with increased risk of infection is associated with gut accumulation of Pseudomonas from the environment. Comput Struct Biotechnol J. 2024;23:2851&#x02013;60.<pub-id pub-id-type="pmid">39100803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Anjos Borges</surname><given-names>LG</given-names></name><name><surname>Pastuschek</surname><given-names>J</given-names></name><name><surname>Heimann</surname><given-names>Y</given-names></name><name><surname>Dawczynski</surname><given-names>K</given-names></name><collab>PEONS study group</collab><name><surname>Schleu&#x000df;ner</surname><given-names>E</given-names></name><etal/></person-group><article-title>Vaginal and neonatal microbiota in pregnant women with preterm premature rupture of membranes and consecutive early onset neonatal sepsis</article-title><source>BMC Med.</source><year>2023</year><volume>21</volume><fpage>92</fpage><?supplied-pmid 36907851?><pub-id pub-id-type="pmid">36907851</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Dos Anjos Borges LG, Pastuschek J, Heimann Y, Dawczynski K, PEONS study group, Schleu&#x000df;ner E, et al. Vaginal and neonatal microbiota in pregnant women with preterm premature rupture of membranes and consecutive early onset neonatal sepsis. BMC Med. 2023;21:92.<pub-id pub-id-type="pmid">36907851</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Ai</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>No microorganism was detected in amniotic fluid of healthy pregnancies from the second trimester to the delivery</article-title><source>Microbiome</source><year>2025</year><volume>13</volume><fpage>20</fpage><?supplied-pmid 39849623?><pub-id pub-id-type="pmid">39849623</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Liu Y, Ma J, Li X, Zhao H, Ai Q, Zhang L, et al. No microorganism was detected in amniotic fluid of healthy pregnancies from the second trimester to the delivery. Microbiome. 2025;13:20.<pub-id pub-id-type="pmid">39849623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Croxen</surname><given-names>MA</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group><article-title>Molecular mechanisms of Escherichia coli pathogenicity</article-title><source>Nat Rev Microbiol</source><year>2010</year><volume>8</volume><fpage>26</fpage><lpage>38</lpage><?supplied-pmid 19966814?><pub-id pub-id-type="pmid">19966814</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26&#x02013;38.<pub-id pub-id-type="pmid">19966814</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Florez</surname><given-names>ID</given-names></name><name><surname>Morgan</surname><given-names>RL</given-names></name><name><surname>Foroutan</surname><given-names>F</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Crandon</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Probiotics, prebiotics, lactoferrin, and combination products for prevention of mortality and morbidity in preterm infants: a systematic review and network meta-analysis</article-title><source>JAMA Pediatr</source><year>2023</year><volume>177</volume><fpage>1158</fpage><lpage>1167</lpage><?supplied-pmid 37782505?><pub-id pub-id-type="pmid">37782505</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Wang Y, Florez ID, Morgan RL, Foroutan F, Chang Y, Crandon HN, et al. Probiotics, prebiotics, lactoferrin, and combination products for prevention of mortality and morbidity in preterm infants: a systematic review and network meta-analysis. JAMA Pediatr. 2023;177:1158&#x02013;67.<pub-id pub-id-type="pmid">37782505</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CW</given-names></name><name><surname>Popovic</surname><given-names>MM</given-names></name><name><surname>Dhoot</surname><given-names>AS</given-names></name><name><surname>Arjmand</surname><given-names>P</given-names></name><name><surname>Muni</surname><given-names>RH</given-names></name><name><surname>Tehrani</surname><given-names>NN</given-names></name><etal/></person-group><article-title>Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies</article-title><source>Neonatology</source><year>2022</year><volume>119</volume><fpage>151</fpage><lpage>163</lpage><?supplied-pmid 35124682?><pub-id pub-id-type="pmid">35124682</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Yu CW, Popovic MM, Dhoot AS, Arjmand P, Muni RH, Tehrani NN, et al. Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies. Neonatology. 2022;119:151&#x02013;63.<pub-id pub-id-type="pmid">35124682</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Been</surname><given-names>JV</given-names></name><name><surname>Rours</surname><given-names>IG</given-names></name><name><surname>Kornelisse</surname><given-names>RF</given-names></name><name><surname>Jonkers</surname><given-names>F</given-names></name><name><surname>de Krijger</surname><given-names>RR</given-names></name><name><surname>Zimmermann</surname><given-names>LJ</given-names></name></person-group><article-title>Chorioamnionitis alters the response to surfactant in preterm infants</article-title><source>J Pediatr</source><year>2010</year><volume>156</volume><fpage>10</fpage><lpage>15.e1</lpage><?supplied-pmid 19833352?><pub-id pub-id-type="pmid">19833352</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Been JV, Rours IG, Kornelisse RF, Jonkers F, de Krijger RR, Zimmermann LJ. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr. 2010;156:10-15.e1.<pub-id pub-id-type="pmid">19833352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Levesque</surname><given-names>BM</given-names></name><name><surname>Kalish</surname><given-names>LA</given-names></name><name><surname>Winston</surname><given-names>AB</given-names></name><name><surname>Parad</surname><given-names>RB</given-names></name><name><surname>Hernandez-Diaz</surname><given-names>S</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><etal/></person-group><article-title>Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity</article-title><source>Neonatology</source><year>2013</year><volume>104</volume><fpage>56</fpage><lpage>64</lpage><?supplied-pmid 23711562?><pub-id pub-id-type="pmid">23711562</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, et al. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013;104:56&#x02013;64.<pub-id pub-id-type="pmid">23711562</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L-W</given-names></name><name><surname>Lin</surname><given-names>Y-C</given-names></name><name><surname>Wang</surname><given-names>S-T</given-names></name><name><surname>Huang</surname><given-names>C-C</given-names></name></person-group><article-title>Identifying risk factors shared by bronchopulmonary dysplasia, severe retinopathy, and cystic periventricular leukomalacia in very preterm infants for targeted intervention</article-title><source>Neonatology</source><year>2018</year><volume>114</volume><fpage>17</fpage><lpage>24</lpage><?supplied-pmid 29621770?><pub-id pub-id-type="pmid">29621770</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Wang L-W, Lin Y-C, Wang S-T, Huang C-C. Identifying risk factors shared by bronchopulmonary dysplasia, severe retinopathy, and cystic periventricular leukomalacia in very preterm infants for targeted intervention. Neonatology. 2018;114:17&#x02013;24.<pub-id pub-id-type="pmid">29621770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Hellstr&#x000f6;m</surname><given-names>A</given-names></name><name><surname>Ley</surname><given-names>D</given-names></name><name><surname>Hansen-Pupp</surname><given-names>I</given-names></name><name><surname>Hallberg</surname><given-names>B</given-names></name><name><surname>Ramenghi</surname><given-names>LA</given-names></name><name><surname>L&#x000f6;fqvist</surname><given-names>C</given-names></name><etal/></person-group><article-title>Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants</article-title><source>Am J Perinatol</source><year>2016</year><volume>33</volume><fpage>1067</fpage><lpage>1071</lpage><?supplied-pmid 27603537?><pub-id pub-id-type="pmid">27603537</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Hellstr&#x000f6;m A, Ley D, Hansen-Pupp I, Hallberg B, Ramenghi LA, L&#x000f6;fqvist C, et al. Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants. Am J Perinatol. 2016;33:1067&#x02013;71.<pub-id pub-id-type="pmid">27603537</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>